Gene Symbol | Gene ID | Gene Info |
---|---|---|
Klf16
|
ENSMUSG00000035397.8 | Kruppel-like factor 16 |
Sp8
|
ENSMUSG00000048562.6 | trans-acting transcription factor 8 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr10_80572548_80572876 | Klf16 | 4609 | 0.085108 | -0.80 | 2.9e-13 | Click! |
chr10_80569782_80569989 | Klf16 | 7436 | 0.076517 | -0.79 | 1.2e-12 | Click! |
chr10_80570071_80570652 | Klf16 | 6960 | 0.077340 | -0.77 | 3.9e-12 | Click! |
chr10_80579002_80579213 | Klf16 | 1786 | 0.152096 | -0.76 | 2.5e-11 | Click! |
chr10_80573311_80573467 | Klf16 | 3932 | 0.090084 | -0.75 | 2.9e-11 | Click! |
chr12_118846303_118846454 | Sp8 | 49 | 0.980153 | 0.65 | 6.2e-08 | Click! |
chr12_118856282_118856433 | Sp8 | 8771 | 0.220361 | 0.63 | 2.1e-07 | Click! |
chr12_118842720_118842871 | Sp8 | 3534 | 0.268546 | 0.59 | 1.7e-06 | Click! |
chr12_118855850_118856001 | Sp8 | 8339 | 0.221857 | 0.54 | 1.8e-05 | Click! |
chr12_118842893_118843385 | Sp8 | 3190 | 0.280401 | 0.54 | 1.9e-05 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr19_61225302_61226760 | 156.55 |
Csf2ra |
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) |
541 |
0.67 |
chr9_124439906_124440949 | 150.72 |
Ppp2r3d |
protein phosphatase 2 (formerly 2A), regulatory subunit B'', delta |
441 |
0.79 |
chr14_14347096_14348750 | 100.65 |
Gm48860 |
predicted gene, 48860 |
659 |
0.44 |
chr12_3236518_3237725 | 92.05 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
510 |
0.74 |
chr11_4572974_4574056 | 91.77 |
Gm11960 |
predicted gene 11960 |
9883 |
0.16 |
chrY_90739614_90740540 | 85.36 |
Mid1-ps1 |
midline 1, pseudogene 1 |
12980 |
0.18 |
chr2_33130296_33131698 | 81.27 |
Garnl3 |
GTPase activating RANGAP domain-like 3 |
389 |
0.84 |
chr14_14350947_14351733 | 79.27 |
Il3ra |
interleukin 3 receptor, alpha chain |
1719 |
0.23 |
chr2_173658978_173659962 | 55.64 |
Ppp4r1l-ps |
protein phosphatase 4, regulatory subunit 1-like, pseudogene |
34 |
0.8 |
chr7_29210966_29212124 | 52.12 |
Catsperg1 |
cation channel sperm associated auxiliary subunit gamma 1 |
50 |
0.94 |
chr5_144357735_144358915 | 49.82 |
Dmrt1i |
Dmrt1 interacting ncRNA |
200 |
0.51 |
chr14_120830371_120830865 | 45.62 |
Gm9391 |
predicted gene 9391 |
3460 |
0.2 |
chr10_81429712_81431957 | 44.98 |
Nfic |
nuclear factor I/C |
171 |
0.85 |
chr19_38054215_38055320 | 43.66 |
I830134H01Rik |
RIKEN cDNA I830134H01 gene |
239 |
0.48 |
chr5_121836427_121837736 | 42.06 |
Sh2b3 |
SH2B adaptor protein 3 |
222 |
0.86 |
chr8_70476397_70477967 | 38.96 |
Klhl26 |
kelch-like 26 |
214 |
0.86 |
chr8_125569269_125570645 | 38.96 |
Sipa1l2 |
signal-induced proliferation-associated 1 like 2 |
149 |
0.97 |
chr16_44687184_44688343 | 38.41 |
Nepro |
nucleolus and neural progenitor protein |
36538 |
0.14 |
chr9_124422847_124423464 | 38.01 |
Ppp2r3d |
protein phosphatase 2 (formerly 2A), regulatory subunit B'', delta |
428 |
0.8 |
chr6_88841841_88842983 | 37.34 |
Abtb1 |
ankyrin repeat and BTB (POZ) domain containing 1 |
428 |
0.42 |
chr12_108333504_108334768 | 34.94 |
Cyp46a1 |
cytochrome P450, family 46, subfamily a, polypeptide 1 |
245 |
0.91 |
chr7_6729309_6729829 | 34.76 |
Peg3 |
paternally expressed 3 |
850 |
0.28 |
chr14_57525179_57526034 | 34.00 |
Il17d |
interleukin 17D |
829 |
0.55 |
chr15_74539884_74540146 | 32.81 |
Adgrb1 |
adhesion G protein-coupled receptor B1 |
382 |
0.85 |
chr5_142701305_142702538 | 32.68 |
Slc29a4 |
solute carrier family 29 (nucleoside transporters), member 4 |
180 |
0.95 |
chr2_3283505_3284761 | 31.79 |
Nmt2 |
N-myristoyltransferase 2 |
79 |
0.97 |
chr16_94526000_94527258 | 30.62 |
Vps26c |
VPS26 endosomal protein sorting factor C |
188 |
0.94 |
chr2_73385763_73387080 | 30.32 |
Gpr155 |
G protein-coupled receptor 155 |
9 |
0.9 |
chr13_54788797_54789586 | 29.96 |
Tspan17 |
tetraspanin 17 |
186 |
0.91 |
chr13_12650037_12651101 | 29.75 |
Gpr137b-ps |
G protein-coupled receptor 137B, pseudogene |
181 |
0.91 |
chr8_70659324_70660479 | 29.41 |
Pgpep1 |
pyroglutamyl-peptidase I |
163 |
0.89 |
chr5_144964803_144965606 | 28.73 |
Smurf1 |
SMAD specific E3 ubiquitin protein ligase 1 |
635 |
0.65 |
chr5_109556763_109557843 | 28.62 |
Crlf2 |
cytokine receptor-like factor 2 |
830 |
0.53 |
chr7_19749021_19749968 | 28.27 |
Nectin2 |
nectin cell adhesion molecule 2 |
39 |
0.93 |
chr7_6727792_6729098 | 28.16 |
Peg3 |
paternally expressed 3 |
1974 |
0.16 |
chr5_65106807_65107827 | 27.91 |
Klhl5 |
kelch-like 5 |
222 |
0.92 |
chr19_10413660_10414496 | 27.80 |
Syt7 |
synaptotagmin VII |
10060 |
0.14 |
chr7_16285532_16286609 | 27.35 |
Ccdc9 |
coiled-coil domain containing 9 |
45 |
0.95 |
chr17_68003632_68004625 | 26.72 |
Arhgap28 |
Rho GTPase activating protein 28 |
8 |
0.99 |
chr8_4677704_4678740 | 26.60 |
Gm7461 |
predicted gene 7461 |
143 |
0.62 |
chr10_70599218_70599723 | 26.59 |
Phyhipl |
phytanoyl-CoA hydroxylase interacting protein-like |
179 |
0.96 |
chr7_44310178_44311500 | 26.57 |
Shank1 |
SH3 and multiple ankyrin repeat domains 1 |
586 |
0.43 |
chr7_19094759_19096427 | 26.49 |
Six5 |
sine oculis-related homeobox 5 |
999 |
0.28 |
chr8_46470414_46471778 | 26.20 |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
24 |
0.97 |
chr12_112112751_112113467 | 25.95 |
Aspg |
asparaginase |
169 |
0.92 |
chr8_122281269_122282287 | 25.64 |
Zfpm1 |
zinc finger protein, multitype 1 |
363 |
0.84 |
chr14_14345884_14346978 | 25.55 |
Il3ra |
interleukin 3 receptor, alpha chain |
1 |
0.93 |
chrX_13346707_13347908 | 25.39 |
Gm7129 |
predicted gene 7129 |
20288 |
0.14 |
chr15_84662949_84663667 | 25.35 |
Prr5 |
proline rich 5 (renal) |
6312 |
0.21 |
chr10_80826008_80827091 | 25.23 |
Oaz1 |
ornithine decarboxylase antizyme 1 |
107 |
0.9 |
chr13_13393240_13394314 | 25.23 |
Gpr137b |
G protein-coupled receptor 137B |
153 |
0.93 |
chr1_89069533_89070748 | 25.21 |
Sh3bp4 |
SH3-domain binding protein 4 |
275 |
0.91 |
chr5_109552541_109552889 | 25.11 |
Gm8493 |
predicted gene 8493 |
1441 |
0.33 |
chr11_120721167_120722110 | 25.00 |
Rac3 |
Rac family small GTPase 3 |
65 |
0.91 |
chr1_21078652_21079573 | 24.70 |
Tram2 |
translocating chain-associating membrane protein 2 |
117 |
0.93 |
chr10_80329105_80330083 | 24.26 |
Pcsk4 |
proprotein convertase subtilisin/kexin type 4 |
96 |
0.76 |
chr16_17927727_17929021 | 24.26 |
Slc25a1 |
solute carrier family 25 (mitochondrial carrier, citrate transporter), member 1 |
155 |
0.9 |
chr14_118812628_118813057 | 24.18 |
n-R5s51 |
nuclear encoded rRNA 5S 51 |
14189 |
0.15 |
chr9_21852119_21853097 | 24.02 |
Dock6 |
dedicator of cytokinesis 6 |
8 |
0.96 |
chr8_70538591_70539987 | 24.02 |
Ell |
elongation factor RNA polymerase II |
168 |
0.88 |
chr9_106452968_106454846 | 23.87 |
Pcbp4 |
poly(rC) binding protein 4 |
8 |
0.92 |
chr9_106886021_106887464 | 23.80 |
Rbm15b |
RNA binding motif protein 15B |
686 |
0.53 |
chr17_35836572_35837313 | 23.69 |
Tubb5 |
tubulin, beta 5 class I |
118 |
0.89 |
chr6_114968557_114970098 | 23.66 |
Vgll4 |
vestigial like family member 4 |
147 |
0.97 |
chr5_24685391_24686443 | 23.62 |
Nub1 |
negative regulator of ubiquitin-like proteins 1 |
70 |
0.96 |
chr9_124439329_124439899 | 23.58 |
Ppp2r3d |
protein phosphatase 2 (formerly 2A), regulatory subunit B'', delta |
1254 |
0.4 |
chr13_55487049_55488117 | 23.26 |
Dbn1 |
drebrin 1 |
50 |
0.94 |
chr15_100614796_100615700 | 23.22 |
Dazap2 |
DAZ associated protein 2 |
101 |
0.53 |
chr10_67978939_67980119 | 23.13 |
Rtkn2 |
rhotekin 2 |
41 |
0.98 |
chr2_26444885_26445708 | 22.98 |
Sec16a |
SEC16 homolog A, endoplasmic reticulum export factor |
80 |
0.82 |
chr4_101068780_101069771 | 22.97 |
Raver2 |
ribonucleoprotein, PTB-binding 2 |
204 |
0.93 |
chr9_21204509_21205302 | 22.71 |
Pde4a |
phosphodiesterase 4A, cAMP specific |
8200 |
0.1 |
chr7_100932502_100932992 | 22.63 |
Arhgef17 |
Rho guanine nucleotide exchange factor (GEF) 17 |
640 |
0.64 |
chr8_71628994_71630252 | 22.29 |
Mir6769b |
microRNA 6769b |
1483 |
0.21 |
chr13_34129793_34130880 | 22.10 |
Tubb2b |
tubulin, beta 2B class IIB |
18 |
0.96 |
chr10_79779826_79781202 | 22.07 |
Fstl3 |
follistatin-like 3 |
67 |
0.92 |
chr5_23675895_23676511 | 22.04 |
Srpk2 |
serine/arginine-rich protein specific kinase 2 |
152 |
0.84 |
chr8_4492910_4494136 | 21.75 |
Cers4 |
ceramide synthase 4 |
2 |
0.97 |
chr5_64739416_64740200 | 21.74 |
Gm20033 |
predicted gene, 20033 |
18051 |
0.15 |
chr7_29169567_29170563 | 21.66 |
Ggn |
gametogenetin |
145 |
0.58 |
chr5_110107192_110108507 | 21.23 |
Gtpbp6 |
GTP binding protein 6 (putative) |
138 |
0.9 |
chr12_30372910_30373696 | 21.11 |
Sntg2 |
syntrophin, gamma 2 |
8 |
0.98 |
chr8_120518680_120519145 | 20.93 |
Gm26971 |
predicted gene, 26971 |
1703 |
0.26 |
chr17_13759899_13761731 | 20.92 |
Afdn |
afadin, adherens junction formation factor |
141 |
0.73 |
chr8_4679817_4680161 | 20.91 |
Gm6410 |
predicted gene 6410 |
1527 |
0.23 |
chr6_120294093_120295041 | 20.89 |
B4galnt3 |
beta-1,4-N-acetyl-galactosaminyl transferase 3 |
8 |
0.98 |
chr5_33982851_33984205 | 20.88 |
Gm1673 |
predicted gene 1673 |
6 |
0.96 |
chr10_83722468_83723424 | 20.80 |
1500009L16Rik |
RIKEN cDNA 1500009L16 gene |
20 |
0.98 |
chr7_84409236_84410328 | 20.68 |
Arnt2 |
aryl hydrocarbon receptor nuclear translocator 2 |
101 |
0.96 |
chr8_88604116_88604818 | 20.61 |
Nkd1 |
naked cuticle 1 |
21662 |
0.15 |
chr8_123514747_123515742 | 20.50 |
Dbndd1 |
dysbindin (dystrobrevin binding protein 1) domain containing 1 |
146 |
0.78 |
chr19_5071354_5072731 | 20.50 |
Tmem151a |
transmembrane protein 151A |
90 |
0.61 |
chr2_102451171_102452295 | 20.46 |
Fjx1 |
four jointed box 1 |
766 |
0.72 |
chr2_28446566_28447382 | 20.36 |
Ppp1r26 |
protein phosphatase 1, regulatory subunit 26 |
108 |
0.95 |
chr8_122284023_122284944 | 20.09 |
Zfpm1 |
zinc finger protein, multitype 1 |
2342 |
0.24 |
chr15_89498976_89499718 | 20.08 |
Shank3 |
SH3 and multiple ankyrin repeat domains 3 |
276 |
0.79 |
chr10_80741710_80742767 | 20.00 |
Ap3d1 |
adaptor-related protein complex 3, delta 1 subunit |
26 |
0.95 |
chr15_58075897_58077232 | 19.97 |
Zhx1 |
zinc fingers and homeoboxes 1 |
23 |
0.63 |
chr4_152138365_152139322 | 19.91 |
Espn |
espin |
2518 |
0.17 |
chrX_150812603_150813957 | 19.84 |
Maged2 |
melanoma antigen, family D, 2 |
126 |
0.95 |
chr14_115040506_115042372 | 19.83 |
Mir17hg |
Mir17 host gene (non-protein coding) |
1440 |
0.19 |
chr8_12873206_12874084 | 19.76 |
Mcf2l |
mcf.2 transforming sequence-like |
161 |
0.92 |
chr1_93176328_93177269 | 19.64 |
Crocc2 |
ciliary rootlet coiled-coil, rootletin family member 2 |
8073 |
0.13 |
chr16_67620882_67621511 | 19.64 |
Cadm2 |
cell adhesion molecule 2 |
288 |
0.94 |
chr7_45784749_45786509 | 19.59 |
Lmtk3 |
lemur tyrosine kinase 3 |
119 |
0.87 |
chr17_46629306_46630520 | 19.57 |
Ptk7 |
PTK7 protein tyrosine kinase 7 |
409 |
0.72 |
chr9_53705535_53706804 | 19.54 |
Rab39 |
RAB39, member RAS oncogene family |
63 |
0.96 |
chr17_66448520_66450314 | 19.30 |
Mtcl1 |
microtubule crosslinking factor 1 |
333 |
0.57 |
chr15_99771905_99772913 | 19.18 |
Cers5 |
ceramide synthase 5 |
53 |
0.94 |
chr13_99514931_99516063 | 19.15 |
Map1b |
microtubule-associated protein 1B |
1021 |
0.37 |
chr2_130397163_130397956 | 19.14 |
Cpxm1 |
carboxypeptidase X 1 (M14 family) |
15 |
0.94 |
chrX_106485268_106485878 | 19.09 |
Fndc3c1 |
fibronectin type III domain containing 3C1 |
172 |
0.95 |
chr17_85687855_85689066 | 19.03 |
Six2 |
sine oculis-related homeobox 2 |
186 |
0.94 |
chr10_81464661_81465630 | 19.03 |
Gm16105 |
predicted gene 16105 |
3986 |
0.08 |
chr5_129941152_129942065 | 19.02 |
Vkorc1l1 |
vitamin K epoxide reductase complex, subunit 1-like 1 |
362 |
0.76 |
chr5_37028527_37029187 | 18.94 |
Jakmip1 |
janus kinase and microtubule interacting protein 1 |
255 |
0.91 |
chr10_78747019_78747870 | 18.87 |
Gm30400 |
predicted gene, 30400 |
285 |
0.85 |
chr3_37419062_37420017 | 18.73 |
Nudt6 |
nudix (nucleoside diphosphate linked moiety X)-type motif 6 |
18 |
0.84 |
chr1_72872536_72872832 | 18.71 |
Igfbp5 |
insulin-like growth factor binding protein 5 |
1591 |
0.43 |
chr8_33992574_33993302 | 18.71 |
Gm45817 |
predicted gene 45817 |
5738 |
0.17 |
chr14_14349938_14350878 | 18.66 |
Il3ra |
interleukin 3 receptor, alpha chain |
787 |
0.48 |
chr8_70791948_70793334 | 18.55 |
Mast3 |
microtubule associated serine/threonine kinase 3 |
204 |
0.83 |
chr18_12947284_12947832 | 18.53 |
Osbpl1a |
oxysterol binding protein-like 1A |
5717 |
0.19 |
chr5_110104232_110105008 | 18.41 |
Gtpbp6 |
GTP binding protein 6 (putative) |
715 |
0.46 |
chr8_71602133_71603459 | 18.29 |
Fam129c |
family with sequence similarity 129, member C |
445 |
0.63 |
chr7_31053000_31053572 | 18.22 |
Fxyd1 |
FXYD domain-containing ion transport regulator 1 |
164 |
0.87 |
chr4_154019719_154020381 | 18.18 |
Lrrc47 |
leucine rich repeat containing 47 |
411 |
0.72 |
chr7_45865731_45866731 | 18.12 |
Grin2d |
glutamate receptor, ionotropic, NMDA2D (epsilon 4) |
898 |
0.32 |
chr14_3332417_3333262 | 18.08 |
Gm2956 |
predicted gene 2956 |
212 |
0.91 |
chr6_122485766_122486276 | 18.01 |
Rimklb |
ribosomal modification protein rimK-like family member B |
418 |
0.77 |
chr15_25621948_25622646 | 17.99 |
Myo10 |
myosin X |
228 |
0.93 |
chr18_24708936_24710320 | 17.91 |
Fhod3 |
formin homology 2 domain containing 3 |
183 |
0.62 |
chr13_51170738_51171698 | 17.90 |
Nxnl2 |
nucleoredoxin-like 2 |
159 |
0.95 |
chr7_73375251_73375992 | 17.89 |
Rgma |
repulsive guidance molecule family member A |
101 |
0.56 |
chr2_3117961_3119194 | 17.73 |
Fam171a1 |
family with sequence similarity 171, member A1 |
108 |
0.97 |
chr6_29434887_29435275 | 17.61 |
Flnc |
filamin C, gamma |
1805 |
0.2 |
chr5_112239158_112239879 | 17.51 |
Miat |
myocardial infarction associated transcript (non-protein coding) |
10123 |
0.11 |
chr2_145674795_145675792 | 17.51 |
Rin2 |
Ras and Rab interactor 2 |
74 |
0.98 |
chr9_21797681_21798988 | 17.48 |
Kank2 |
KN motif and ankyrin repeat domains 2 |
169 |
0.91 |
chr4_91371091_91372260 | 17.47 |
Elavl2 |
ELAV like RNA binding protein 1 |
281 |
0.88 |
chr2_94273064_94274137 | 17.43 |
Mir670hg |
MIR670 host gene (non-protein coding) |
8682 |
0.15 |
chr6_72958015_72959038 | 17.34 |
Tmsb10 |
thymosin, beta 10 |
38 |
0.97 |
chr18_74064418_74065509 | 17.34 |
Mapk4 |
mitogen-activated protein kinase 4 |
34 |
0.63 |
chr6_22874878_22875647 | 17.32 |
Ptprz1 |
protein tyrosine phosphatase, receptor type Z, polypeptide 1 |
240 |
0.94 |
chr8_84990346_84991110 | 17.31 |
Hook2 |
hook microtubule tethering protein 2 |
86 |
0.9 |
chr8_71686115_71686959 | 17.29 |
Insl3 |
insulin-like 3 |
2677 |
0.12 |
chr14_99045440_99046902 | 17.27 |
Mzt1 |
mitotic spindle organizing protein 1 |
37 |
0.51 |
chr2_138256185_138257474 | 17.25 |
Btbd3 |
BTB (POZ) domain containing 3 |
159 |
0.98 |
chr9_122571793_122572853 | 17.21 |
9530059O14Rik |
RIKEN cDNA 9530059O14 gene |
176 |
0.93 |
chr18_46311791_46312285 | 17.20 |
Ccdc112 |
coiled-coil domain containing 112 |
110 |
0.96 |
chr11_98959522_98960759 | 17.15 |
Rara |
retinoic acid receptor, alpha |
272 |
0.84 |
chr14_6037512_6038662 | 17.15 |
Gm8206 |
predicted gene 8206 |
122 |
0.93 |
chr10_79681206_79682337 | 17.12 |
Cdc34 |
cell division cycle 34 |
424 |
0.63 |
chr5_97111500_97112336 | 17.01 |
Paqr3 |
progestin and adipoQ receptor family member III |
322 |
0.89 |
chr8_71374903_71376449 | 16.95 |
Nr2f6 |
nuclear receptor subfamily 2, group F, member 6 |
114 |
0.92 |
chr5_112276495_112277340 | 16.94 |
Tpst2 |
protein-tyrosine sulfotransferase 2 |
210 |
0.9 |
chr15_78835129_78836581 | 16.91 |
Cdc42ep1 |
CDC42 effector protein (Rho GTPase binding) 1 |
6769 |
0.09 |
chr16_18629072_18630255 | 16.85 |
Septin5 |
septin 5 |
41 |
0.96 |
chr16_44632721_44633371 | 16.81 |
Boc |
biregional cell adhesion molecule-related/down-regulated by oncogenes (Cdon) binding protein |
74149 |
0.08 |
chr8_70315603_70316677 | 16.72 |
Cers1 |
ceramide synthase 1 |
353 |
0.75 |
chr7_38106770_38108111 | 16.70 |
Ccne1 |
cyclin E1 |
62 |
0.97 |
chr4_120854573_120855281 | 16.68 |
Rims3 |
regulating synaptic membrane exocytosis 3 |
108 |
0.95 |
chr5_25498778_25500023 | 16.67 |
Kmt2c |
lysine (K)-specific methyltransferase 2C |
617 |
0.62 |
chr7_34570196_34571084 | 16.62 |
Gm12784 |
predicted gene 12784 |
23434 |
0.15 |
chr4_119733256_119734302 | 16.60 |
Hivep3 |
human immunodeficiency virus type I enhancer binding protein 3 |
5 |
0.98 |
chr9_122294282_122295077 | 16.58 |
Ano10 |
anoctamin 10 |
256 |
0.84 |
chr2_93187957_93189155 | 16.56 |
Trp53i11 |
transformation related protein 53 inducible protein 11 |
635 |
0.76 |
chr4_145463625_145464359 | 16.54 |
Smarca5-ps |
SWI/SNF related, matrix associated, actin depenent ragulator of chromatin, subfamily a, member 5, pseudogene |
212 |
0.89 |
chr17_56626470_56627486 | 16.40 |
Lonp1 |
lon peptidase 1, mitochondrial |
91 |
0.92 |
chr10_60193469_60194525 | 16.39 |
Chst3 |
carbohydrate sulfotransferase 3 |
242 |
0.93 |
chr14_7314343_7315443 | 16.35 |
Gm3739 |
predicted gene 3739 |
156 |
0.94 |
chr10_77902919_77903521 | 16.29 |
Lrrc3 |
leucine rich repeat containing 3 |
684 |
0.44 |
chr7_35754026_35754910 | 16.27 |
Dpy19l3 |
dpy-19-like 3 (C. elegans) |
14 |
0.98 |
chr4_118620310_118621356 | 16.22 |
Ebna1bp2 |
EBNA1 binding protein 2 |
15 |
0.52 |
chr4_152273539_152274471 | 16.22 |
Gpr153 |
G protein-coupled receptor 153 |
227 |
0.89 |
chr5_117125754_117126245 | 16.19 |
Taok3 |
TAO kinase 3 |
302 |
0.86 |
chr9_104002273_104002941 | 16.17 |
Nphp3 |
nephronophthisis 3 (adolescent) |
47 |
0.77 |
chr2_165511107_165511805 | 16.16 |
Slc2a10 |
solute carrier family 2 (facilitated glucose transporter), member 10 |
2675 |
0.23 |
chr11_108910934_108911269 | 16.16 |
Axin2 |
axin 2 |
9248 |
0.21 |
chr17_25433917_25434633 | 16.15 |
Cacna1h |
calcium channel, voltage-dependent, T type, alpha 1H subunit |
492 |
0.69 |
chr7_25802241_25803073 | 16.13 |
Gm45226 |
predicted gene 45226 |
7518 |
0.08 |
chr15_74487345_74487780 | 16.03 |
Adgrb1 |
adhesion G protein-coupled receptor B1 |
28633 |
0.16 |
chr5_45449714_45450578 | 16.01 |
Qdpr |
quinoid dihydropteridine reductase |
8 |
0.96 |
chr15_32244351_32244917 | 15.91 |
Snhg18 |
small nucleolar RNA host gene 18 |
28 |
0.68 |
chr9_48984513_48985876 | 15.91 |
Usp28 |
ubiquitin specific peptidase 28 |
181 |
0.94 |
chr3_121723245_121724172 | 15.89 |
F3 |
coagulation factor III |
138 |
0.7 |
chr12_3364588_3366025 | 15.86 |
Kif3c |
kinesin family member 3C |
116 |
0.94 |
chr5_73647229_73648112 | 15.84 |
Gm43799 |
predicted gene 43799 |
79 |
0.55 |
chr7_139085918_139086752 | 15.79 |
Dpysl4 |
dihydropyrimidinase-like 4 |
307 |
0.89 |
chr6_99666291_99667273 | 15.72 |
Eif4e3 |
eukaryotic translation initiation factor 4E member 3 |
11 |
0.49 |
chr7_45332643_45333917 | 15.67 |
Trpm4 |
transient receptor potential cation channel, subfamily M, member 4 |
376 |
0.63 |
chr14_3948585_3949537 | 15.64 |
Gm3095 |
predicted gene 3095 |
14486 |
0.11 |
chr2_151701768_151703133 | 15.64 |
Tmem74b |
transmembrane protein 74B |
139 |
0.92 |
chr14_45388403_45389548 | 15.56 |
Gnpnat1 |
glucosamine-phosphate N-acetyltransferase 1 |
14 |
0.96 |
chr10_81559146_81561402 | 15.56 |
Tle5 |
TLE family member 5, transcriptional modulator |
770 |
0.38 |
chr11_100355115_100355864 | 15.55 |
Hap1 |
huntingtin-associated protein 1 |
106 |
0.91 |
chr3_153943944_153945147 | 15.52 |
Acadm |
acyl-Coenzyme A dehydrogenase, medium chain |
78 |
0.95 |
chr7_6382694_6383817 | 15.48 |
Zfp28 |
zinc finger protein 28 |
40 |
0.94 |
chr7_45361179_45361983 | 15.47 |
Ppfia3 |
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3 |
241 |
0.77 |
chr1_3671269_3672324 | 15.45 |
Xkr4 |
X-linked Kx blood group related 4 |
298 |
0.89 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
18.2 | 127.7 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
16.0 | 48.1 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
14.3 | 14.3 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
13.4 | 40.2 | GO:0061642 | chemoattraction of axon(GO:0061642) |
13.3 | 39.8 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
12.3 | 36.8 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
11.6 | 34.8 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
11.3 | 33.9 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
11.2 | 56.1 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
10.9 | 32.7 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
10.8 | 118.5 | GO:0071625 | vocalization behavior(GO:0071625) |
10.7 | 32.2 | GO:0070384 | Harderian gland development(GO:0070384) |
10.2 | 61.0 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
10.1 | 30.3 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
10.0 | 30.1 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
9.8 | 29.4 | GO:0060594 | mammary gland specification(GO:0060594) |
9.8 | 39.2 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
9.4 | 28.2 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
9.0 | 63.0 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
8.9 | 26.7 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
8.8 | 26.5 | GO:0021564 | vagus nerve development(GO:0021564) |
8.8 | 61.7 | GO:0060601 | lateral sprouting from an epithelium(GO:0060601) |
8.8 | 26.4 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
8.8 | 26.3 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
8.7 | 17.3 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
8.6 | 42.8 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
8.4 | 33.5 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
8.2 | 8.2 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
8.2 | 32.7 | GO:0007412 | axon target recognition(GO:0007412) |
8.2 | 49.0 | GO:1904424 | regulation of GTP binding(GO:1904424) |
8.2 | 16.3 | GO:0072198 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
8.1 | 16.2 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
8.1 | 24.3 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
8.1 | 24.2 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
8.0 | 24.0 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
8.0 | 39.9 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
7.8 | 31.3 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
7.8 | 7.8 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
7.8 | 38.8 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
7.7 | 15.5 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
7.7 | 15.4 | GO:0021586 | pons maturation(GO:0021586) |
7.7 | 69.4 | GO:0051764 | actin crosslink formation(GO:0051764) |
7.7 | 15.3 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
7.6 | 38.0 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
7.4 | 7.4 | GO:1902988 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
7.3 | 7.3 | GO:0097104 | postsynaptic membrane assembly(GO:0097104) |
7.3 | 14.6 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
7.3 | 21.9 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
7.3 | 14.5 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
7.1 | 21.3 | GO:0071492 | cellular response to UV-A(GO:0071492) |
7.0 | 21.1 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
7.0 | 7.0 | GO:0060066 | oviduct development(GO:0060066) |
7.0 | 14.1 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
7.0 | 21.0 | GO:0061743 | motor learning(GO:0061743) |
6.9 | 27.7 | GO:0030035 | microspike assembly(GO:0030035) |
6.9 | 27.7 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
6.9 | 20.7 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
6.9 | 27.6 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
6.9 | 13.8 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
6.9 | 20.7 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
6.9 | 27.5 | GO:0060591 | chondroblast differentiation(GO:0060591) |
6.9 | 6.9 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
6.8 | 27.4 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
6.8 | 20.4 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
6.6 | 19.8 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
6.6 | 13.2 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
6.6 | 13.2 | GO:0035290 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
6.6 | 19.7 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
6.5 | 6.5 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
6.5 | 32.5 | GO:0035989 | tendon development(GO:0035989) |
6.4 | 6.4 | GO:0061551 | trigeminal ganglion development(GO:0061551) |
6.3 | 95.0 | GO:0007413 | axonal fasciculation(GO:0007413) |
6.3 | 50.1 | GO:0071420 | cellular response to histamine(GO:0071420) |
6.2 | 6.2 | GO:1905049 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
6.2 | 6.2 | GO:0086017 | Purkinje myocyte action potential(GO:0086017) |
6.2 | 37.3 | GO:0046069 | cGMP catabolic process(GO:0046069) |
6.2 | 12.4 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
6.2 | 6.2 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
6.1 | 18.3 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
6.1 | 18.2 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
6.0 | 18.1 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
6.0 | 18.1 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
6.0 | 42.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
6.0 | 6.0 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
6.0 | 11.9 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
5.9 | 17.8 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
5.9 | 17.6 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
5.9 | 35.3 | GO:0016198 | axon choice point recognition(GO:0016198) |
5.8 | 40.5 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
5.8 | 23.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
5.7 | 17.2 | GO:0003192 | mitral valve formation(GO:0003192) |
5.7 | 5.7 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
5.6 | 16.9 | GO:0061438 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
5.6 | 5.6 | GO:0003195 | tricuspid valve morphogenesis(GO:0003186) tricuspid valve formation(GO:0003195) |
5.5 | 16.6 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
5.5 | 33.3 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
5.5 | 22.0 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
5.5 | 5.5 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
5.5 | 5.5 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
5.5 | 16.4 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
5.4 | 27.2 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
5.4 | 21.5 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
5.4 | 16.2 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
5.3 | 10.7 | GO:0035262 | gonad morphogenesis(GO:0035262) |
5.3 | 26.5 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
5.2 | 10.5 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
5.2 | 31.2 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
5.1 | 15.4 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
5.1 | 15.4 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
5.1 | 25.7 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
5.1 | 15.4 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
5.1 | 20.5 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
5.1 | 15.4 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
5.1 | 15.3 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
5.1 | 20.4 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
5.1 | 15.2 | GO:0044704 | single-organism reproductive behavior(GO:0044704) |
5.1 | 30.4 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
5.1 | 40.4 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
5.0 | 15.1 | GO:0072092 | ureteric bud invasion(GO:0072092) |
5.0 | 45.3 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
5.0 | 9.9 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
5.0 | 19.8 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
5.0 | 19.8 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
5.0 | 19.8 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
5.0 | 19.8 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
5.0 | 14.9 | GO:0010288 | response to lead ion(GO:0010288) |
4.9 | 4.9 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
4.9 | 24.7 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
4.9 | 9.9 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
4.9 | 24.6 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
4.9 | 19.6 | GO:0023041 | neuronal signal transduction(GO:0023041) |
4.9 | 14.6 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
4.9 | 9.7 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
4.8 | 19.4 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
4.8 | 9.7 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
4.8 | 14.5 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
4.8 | 14.3 | GO:0071895 | odontoblast differentiation(GO:0071895) |
4.8 | 14.3 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
4.8 | 14.3 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
4.7 | 9.5 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
4.7 | 18.9 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
4.7 | 14.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
4.7 | 4.7 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
4.7 | 23.3 | GO:0006528 | asparagine metabolic process(GO:0006528) |
4.6 | 13.9 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
4.6 | 18.5 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
4.6 | 18.4 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
4.6 | 27.6 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
4.6 | 4.6 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
4.5 | 9.1 | GO:0072162 | metanephric mesenchymal cell differentiation(GO:0072162) |
4.5 | 9.1 | GO:0046684 | response to pyrethroid(GO:0046684) |
4.5 | 13.5 | GO:0048865 | stem cell fate commitment(GO:0048865) |
4.5 | 9.0 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
4.5 | 18.0 | GO:0042940 | D-amino acid transport(GO:0042940) |
4.5 | 9.0 | GO:0071873 | response to norepinephrine(GO:0071873) |
4.5 | 31.4 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
4.5 | 4.5 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
4.5 | 9.0 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
4.4 | 13.2 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
4.4 | 13.1 | GO:0060486 | Clara cell differentiation(GO:0060486) |
4.4 | 13.1 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
4.4 | 17.5 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
4.3 | 17.4 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
4.3 | 34.7 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
4.3 | 4.3 | GO:0099612 | protein localization to axon(GO:0099612) |
4.3 | 25.8 | GO:0042118 | endothelial cell activation(GO:0042118) |
4.3 | 8.6 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
4.3 | 17.1 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
4.3 | 8.5 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
4.3 | 4.3 | GO:0048320 | axial mesoderm formation(GO:0048320) |
4.3 | 8.5 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
4.2 | 8.5 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
4.2 | 12.7 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
4.2 | 4.2 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
4.2 | 33.7 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
4.2 | 8.4 | GO:1903055 | positive regulation of extracellular matrix organization(GO:1903055) regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
4.2 | 37.4 | GO:0060068 | vagina development(GO:0060068) |
4.1 | 29.0 | GO:0099515 | actin filament-based transport(GO:0099515) |
4.1 | 12.4 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
4.1 | 24.5 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
4.1 | 20.3 | GO:0035878 | nail development(GO:0035878) |
4.1 | 69.0 | GO:0001964 | startle response(GO:0001964) |
4.0 | 16.1 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
4.0 | 12.1 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
4.0 | 8.0 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
4.0 | 8.0 | GO:0061205 | paramesonephric duct development(GO:0061205) |
4.0 | 12.0 | GO:0060468 | prevention of polyspermy(GO:0060468) |
4.0 | 12.0 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
4.0 | 20.0 | GO:2001023 | regulation of response to drug(GO:2001023) |
4.0 | 8.0 | GO:0051944 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
4.0 | 11.9 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
4.0 | 19.8 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
3.9 | 23.6 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
3.9 | 3.9 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
3.9 | 31.2 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
3.9 | 15.5 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
3.9 | 11.6 | GO:0045759 | negative regulation of action potential(GO:0045759) |
3.9 | 7.7 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
3.8 | 7.7 | GO:0008038 | neuron recognition(GO:0008038) |
3.8 | 15.3 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
3.8 | 11.5 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
3.8 | 7.6 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
3.8 | 30.4 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
3.8 | 15.2 | GO:0021764 | amygdala development(GO:0021764) |
3.8 | 15.2 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
3.8 | 188.6 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
3.8 | 11.3 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
3.8 | 7.5 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
3.7 | 11.2 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
3.7 | 298.6 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
3.7 | 7.4 | GO:0021570 | rhombomere 4 development(GO:0021570) |
3.7 | 7.4 | GO:0072174 | metanephric tubule formation(GO:0072174) |
3.7 | 3.7 | GO:0060384 | innervation(GO:0060384) |
3.7 | 11.0 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
3.7 | 11.0 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
3.6 | 10.9 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
3.6 | 3.6 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
3.6 | 10.9 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
3.6 | 14.5 | GO:0046958 | nonassociative learning(GO:0046958) |
3.6 | 10.8 | GO:0097503 | sialylation(GO:0097503) |
3.6 | 7.2 | GO:0021892 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) |
3.6 | 10.7 | GO:0032474 | otolith morphogenesis(GO:0032474) |
3.6 | 10.7 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
3.6 | 7.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
3.5 | 7.1 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
3.5 | 3.5 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) |
3.5 | 3.5 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
3.5 | 10.5 | GO:0002930 | trabecular meshwork development(GO:0002930) |
3.5 | 3.5 | GO:0071321 | response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
3.5 | 17.4 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
3.5 | 10.4 | GO:0086018 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
3.5 | 3.5 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
3.5 | 10.4 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
3.5 | 6.9 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
3.4 | 20.7 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
3.4 | 20.7 | GO:0070314 | G1 to G0 transition(GO:0070314) |
3.4 | 3.4 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
3.4 | 3.4 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
3.4 | 20.3 | GO:0099625 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
3.4 | 20.3 | GO:0005513 | detection of calcium ion(GO:0005513) |
3.4 | 3.4 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
3.4 | 16.9 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
3.4 | 10.1 | GO:0043307 | eosinophil activation(GO:0043307) |
3.4 | 20.2 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
3.3 | 3.3 | GO:0051138 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
3.3 | 3.3 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
3.3 | 13.3 | GO:0051639 | actin filament network formation(GO:0051639) |
3.3 | 6.7 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
3.3 | 9.9 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
3.3 | 16.5 | GO:0015884 | folic acid transport(GO:0015884) |
3.3 | 6.6 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
3.3 | 3.3 | GO:0065001 | specification of axis polarity(GO:0065001) |
3.3 | 6.5 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
3.2 | 9.7 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
3.2 | 13.0 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
3.2 | 3.2 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
3.2 | 16.1 | GO:0010996 | response to auditory stimulus(GO:0010996) |
3.2 | 6.4 | GO:0060166 | olfactory pit development(GO:0060166) |
3.2 | 9.6 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
3.2 | 15.9 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
3.2 | 3.2 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
3.2 | 3.2 | GO:0014900 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
3.2 | 3.2 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
3.2 | 9.5 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
3.2 | 3.2 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
3.2 | 3.2 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
3.2 | 6.3 | GO:0090135 | actin filament branching(GO:0090135) |
3.2 | 9.5 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
3.1 | 40.8 | GO:0003416 | endochondral bone growth(GO:0003416) |
3.1 | 9.4 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
3.1 | 6.3 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
3.1 | 18.8 | GO:0048251 | elastic fiber assembly(GO:0048251) |
3.1 | 6.2 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
3.1 | 24.9 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
3.1 | 3.1 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
3.1 | 9.3 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
3.1 | 6.2 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
3.1 | 9.3 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
3.1 | 9.2 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
3.1 | 18.4 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
3.1 | 6.1 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
3.1 | 6.1 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
3.1 | 6.1 | GO:0021557 | oculomotor nerve development(GO:0021557) |
3.0 | 36.6 | GO:0048268 | clathrin coat assembly(GO:0048268) |
3.0 | 12.2 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
3.0 | 3.0 | GO:0072173 | metanephric tubule morphogenesis(GO:0072173) |
3.0 | 6.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
3.0 | 6.1 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
3.0 | 6.0 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
3.0 | 38.9 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
3.0 | 6.0 | GO:0003181 | atrioventricular valve morphogenesis(GO:0003181) |
3.0 | 8.9 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
2.9 | 20.6 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
2.9 | 11.8 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
2.9 | 2.9 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
2.9 | 5.9 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
2.9 | 41.0 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
2.9 | 8.8 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
2.9 | 11.7 | GO:1902307 | positive regulation of sodium ion transmembrane transport(GO:1902307) |
2.9 | 8.8 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
2.9 | 5.8 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
2.9 | 17.4 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
2.9 | 20.3 | GO:0021884 | forebrain neuron development(GO:0021884) |
2.9 | 11.5 | GO:0021871 | forebrain regionalization(GO:0021871) |
2.9 | 5.7 | GO:0008355 | olfactory learning(GO:0008355) |
2.9 | 5.7 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
2.8 | 2.8 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
2.8 | 5.7 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
2.8 | 5.7 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
2.8 | 8.5 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
2.8 | 11.3 | GO:0021854 | hypothalamus development(GO:0021854) |
2.8 | 5.7 | GO:0048696 | collateral sprouting in absence of injury(GO:0048669) regulation of collateral sprouting in absence of injury(GO:0048696) |
2.8 | 5.6 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
2.8 | 5.6 | GO:0061037 | negative regulation of cartilage development(GO:0061037) |
2.8 | 5.6 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
2.8 | 58.8 | GO:0030224 | monocyte differentiation(GO:0030224) |
2.8 | 8.4 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
2.8 | 8.4 | GO:0060347 | heart trabecula formation(GO:0060347) |
2.8 | 2.8 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
2.8 | 11.1 | GO:0030091 | protein repair(GO:0030091) |
2.8 | 2.8 | GO:0035799 | ureter maturation(GO:0035799) |
2.8 | 19.3 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
2.8 | 2.8 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
2.8 | 8.3 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
2.7 | 5.5 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
2.7 | 8.2 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
2.7 | 30.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
2.7 | 2.7 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
2.7 | 2.7 | GO:0048664 | neuron fate determination(GO:0048664) |
2.7 | 2.7 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
2.7 | 16.1 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
2.7 | 5.3 | GO:0046880 | regulation of follicle-stimulating hormone secretion(GO:0046880) |
2.7 | 16.0 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
2.7 | 8.0 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
2.7 | 2.7 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) nephrogenic mesenchyme development(GO:0072076) |
2.7 | 8.0 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
2.7 | 2.7 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
2.7 | 23.9 | GO:0006020 | inositol metabolic process(GO:0006020) |
2.7 | 10.6 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
2.7 | 10.6 | GO:0048484 | enteric nervous system development(GO:0048484) |
2.6 | 5.3 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
2.6 | 5.3 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
2.6 | 18.3 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
2.6 | 7.8 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
2.6 | 7.8 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
2.6 | 7.8 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
2.6 | 23.3 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
2.6 | 7.7 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
2.6 | 18.0 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
2.6 | 5.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
2.6 | 2.6 | GO:0021978 | telencephalon regionalization(GO:0021978) |
2.5 | 22.9 | GO:0048663 | neuron fate commitment(GO:0048663) |
2.5 | 10.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
2.5 | 5.1 | GO:0061047 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
2.5 | 15.2 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
2.5 | 50.6 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
2.5 | 15.0 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
2.5 | 2.5 | GO:0032225 | regulation of synaptic transmission, dopaminergic(GO:0032225) |
2.5 | 2.5 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
2.5 | 22.4 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
2.5 | 5.0 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
2.5 | 12.4 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
2.5 | 7.4 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
2.5 | 9.8 | GO:0061339 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
2.4 | 7.3 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
2.4 | 2.4 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
2.4 | 7.3 | GO:1904970 | brush border assembly(GO:1904970) |
2.4 | 4.8 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
2.4 | 9.7 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
2.4 | 2.4 | GO:0090179 | planar cell polarity pathway involved in neural tube closure(GO:0090179) |
2.4 | 9.6 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
2.4 | 4.8 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
2.4 | 9.5 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
2.4 | 7.1 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
2.4 | 9.5 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
2.4 | 7.1 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
2.4 | 4.7 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
2.4 | 4.7 | GO:2000619 | negative regulation of histone H4-K16 acetylation(GO:2000619) |
2.4 | 7.1 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
2.4 | 7.1 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
2.4 | 35.3 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
2.4 | 9.4 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
2.3 | 7.0 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
2.3 | 2.3 | GO:1901017 | negative regulation of potassium ion transmembrane transporter activity(GO:1901017) |
2.3 | 28.1 | GO:0061462 | protein localization to lysosome(GO:0061462) |
2.3 | 4.7 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
2.3 | 14.0 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
2.3 | 4.6 | GO:0050805 | negative regulation of synaptic transmission(GO:0050805) |
2.3 | 7.0 | GO:0060437 | lung growth(GO:0060437) |
2.3 | 34.8 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
2.3 | 2.3 | GO:0090427 | activation of meiosis(GO:0090427) |
2.3 | 6.9 | GO:0030070 | insulin processing(GO:0030070) |
2.3 | 48.5 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
2.3 | 4.6 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
2.3 | 6.9 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
2.3 | 27.4 | GO:0016486 | peptide hormone processing(GO:0016486) |
2.3 | 4.6 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
2.3 | 2.3 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
2.3 | 2.3 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
2.3 | 2.3 | GO:0032349 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
2.3 | 2.3 | GO:0060596 | mammary placode formation(GO:0060596) |
2.3 | 2.3 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
2.3 | 2.3 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
2.2 | 4.5 | GO:0007494 | midgut development(GO:0007494) |
2.2 | 2.2 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
2.2 | 4.5 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
2.2 | 2.2 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
2.2 | 8.9 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
2.2 | 24.4 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
2.2 | 11.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
2.2 | 10.9 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
2.2 | 2.2 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
2.2 | 4.3 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
2.2 | 88.3 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
2.1 | 2.1 | GO:0015819 | lysine transport(GO:0015819) |
2.1 | 2.1 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
2.1 | 27.7 | GO:0021846 | cell proliferation in forebrain(GO:0021846) |
2.1 | 6.4 | GO:0032252 | secretory granule localization(GO:0032252) |
2.1 | 4.3 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
2.1 | 12.7 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
2.1 | 6.3 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
2.1 | 31.4 | GO:0098926 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
2.1 | 4.2 | GO:0010963 | regulation of L-arginine import(GO:0010963) |
2.1 | 31.2 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
2.1 | 6.2 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
2.1 | 6.2 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
2.1 | 74.3 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
2.1 | 2.1 | GO:1902992 | negative regulation of amyloid precursor protein catabolic process(GO:1902992) |
2.1 | 2.1 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
2.1 | 4.1 | GO:0001757 | somite specification(GO:0001757) |
2.1 | 4.1 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
2.1 | 10.3 | GO:0048532 | anatomical structure arrangement(GO:0048532) |
2.1 | 6.2 | GO:0032513 | negative regulation of protein phosphatase type 2B activity(GO:0032513) |
2.0 | 8.2 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
2.0 | 8.2 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
2.0 | 8.1 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
2.0 | 14.2 | GO:0072112 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
2.0 | 12.2 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
2.0 | 6.1 | GO:0030421 | defecation(GO:0030421) |
2.0 | 18.0 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
2.0 | 4.0 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
2.0 | 15.9 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
2.0 | 2.0 | GO:0060214 | endocardium formation(GO:0060214) |
2.0 | 9.9 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
2.0 | 21.7 | GO:0001755 | neural crest cell migration(GO:0001755) |
2.0 | 3.9 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
2.0 | 5.9 | GO:2000035 | regulation of stem cell division(GO:2000035) |
2.0 | 2.0 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
2.0 | 2.0 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
1.9 | 3.9 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
1.9 | 3.9 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
1.9 | 1.9 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
1.9 | 9.7 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
1.9 | 1.9 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
1.9 | 17.4 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
1.9 | 5.8 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
1.9 | 15.5 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
1.9 | 17.4 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
1.9 | 9.7 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
1.9 | 5.8 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
1.9 | 5.8 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
1.9 | 11.5 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
1.9 | 1.9 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
1.9 | 1.9 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
1.9 | 1.9 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
1.9 | 5.7 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
1.9 | 7.6 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
1.9 | 3.8 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
1.9 | 45.3 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
1.9 | 3.8 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
1.9 | 15.0 | GO:0007135 | meiosis II(GO:0007135) |
1.9 | 3.7 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
1.9 | 1.9 | GO:0015705 | iodide transport(GO:0015705) |
1.9 | 1.9 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
1.9 | 3.7 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
1.9 | 11.1 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
1.8 | 9.2 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
1.8 | 3.7 | GO:0045402 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
1.8 | 9.1 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
1.8 | 1.8 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
1.8 | 1.8 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
1.8 | 19.9 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
1.8 | 5.4 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
1.8 | 5.4 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
1.8 | 16.2 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
1.8 | 14.3 | GO:0097120 | receptor localization to synapse(GO:0097120) |
1.8 | 5.3 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
1.8 | 1.8 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
1.8 | 1.8 | GO:0072053 | renal inner medulla development(GO:0072053) |
1.8 | 1.8 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
1.8 | 3.5 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) |
1.8 | 17.6 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
1.8 | 19.4 | GO:0003334 | keratinocyte development(GO:0003334) |
1.8 | 3.5 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
1.8 | 8.8 | GO:0033604 | negative regulation of catecholamine secretion(GO:0033604) |
1.7 | 26.2 | GO:0007416 | synapse assembly(GO:0007416) |
1.7 | 13.8 | GO:0030903 | notochord development(GO:0030903) |
1.7 | 5.2 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
1.7 | 8.6 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
1.7 | 22.3 | GO:0044458 | motile cilium assembly(GO:0044458) |
1.7 | 85.5 | GO:0097485 | neuron projection guidance(GO:0097485) |
1.7 | 5.1 | GO:0035137 | hindlimb morphogenesis(GO:0035137) |
1.7 | 3.4 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
1.7 | 5.1 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
1.7 | 6.8 | GO:1903012 | positive regulation of bone development(GO:1903012) |
1.7 | 11.8 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
1.7 | 3.4 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
1.7 | 10.1 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
1.7 | 48.8 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
1.7 | 6.7 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
1.7 | 15.1 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
1.7 | 3.3 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
1.7 | 3.3 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
1.7 | 11.7 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
1.7 | 6.6 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
1.7 | 6.6 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
1.7 | 5.0 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
1.6 | 1.6 | GO:0021794 | thalamus development(GO:0021794) |
1.6 | 13.1 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
1.6 | 6.6 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
1.6 | 3.3 | GO:0015888 | thiamine transport(GO:0015888) |
1.6 | 11.4 | GO:0060292 | long term synaptic depression(GO:0060292) |
1.6 | 4.9 | GO:0002317 | plasma cell differentiation(GO:0002317) |
1.6 | 6.5 | GO:0051697 | protein delipidation(GO:0051697) |
1.6 | 38.6 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
1.6 | 3.2 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
1.6 | 3.2 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
1.6 | 1.6 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
1.6 | 3.2 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
1.6 | 17.5 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
1.6 | 1.6 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
1.6 | 4.8 | GO:1901020 | negative regulation of calcium ion transmembrane transporter activity(GO:1901020) |
1.6 | 3.2 | GO:0061055 | myotome development(GO:0061055) |
1.6 | 3.2 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
1.6 | 15.8 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
1.6 | 3.2 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
1.6 | 4.7 | GO:0042160 | plasma lipoprotein particle oxidation(GO:0034441) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
1.6 | 12.5 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
1.5 | 4.6 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
1.5 | 4.6 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
1.5 | 3.1 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
1.5 | 3.1 | GO:0072578 | neurotransmitter-gated ion channel clustering(GO:0072578) |
1.5 | 3.1 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
1.5 | 3.1 | GO:0061005 | cell differentiation involved in kidney development(GO:0061005) |
1.5 | 1.5 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
1.5 | 6.1 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
1.5 | 3.0 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
1.5 | 10.6 | GO:0006108 | malate metabolic process(GO:0006108) |
1.5 | 4.5 | GO:0002159 | desmosome assembly(GO:0002159) |
1.5 | 4.5 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
1.5 | 3.0 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
1.5 | 4.5 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
1.5 | 1.5 | GO:0035995 | detection of muscle stretch(GO:0035995) |
1.5 | 4.5 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
1.5 | 4.5 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
1.5 | 130.5 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
1.5 | 4.4 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
1.5 | 10.3 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
1.5 | 1.5 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
1.5 | 2.9 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
1.5 | 7.3 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
1.5 | 2.9 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
1.5 | 1.5 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
1.4 | 4.3 | GO:0051466 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
1.4 | 4.3 | GO:0060179 | male mating behavior(GO:0060179) |
1.4 | 4.3 | GO:0031296 | B cell costimulation(GO:0031296) |
1.4 | 5.8 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
1.4 | 4.3 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
1.4 | 5.8 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
1.4 | 4.3 | GO:0006566 | threonine metabolic process(GO:0006566) |
1.4 | 4.3 | GO:0006562 | proline catabolic process(GO:0006562) |
1.4 | 1.4 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
1.4 | 4.3 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
1.4 | 1.4 | GO:0001927 | exocyst assembly(GO:0001927) |
1.4 | 11.4 | GO:0010842 | retina layer formation(GO:0010842) |
1.4 | 5.7 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
1.4 | 2.8 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
1.4 | 5.6 | GO:0031000 | response to caffeine(GO:0031000) |
1.4 | 5.6 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
1.4 | 1.4 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
1.4 | 1.4 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
1.4 | 5.5 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
1.4 | 9.6 | GO:0031643 | positive regulation of myelination(GO:0031643) |
1.4 | 12.2 | GO:0042559 | folic acid-containing compound biosynthetic process(GO:0009396) pteridine-containing compound biosynthetic process(GO:0042559) |
1.4 | 1.4 | GO:2001170 | positive regulation of fat cell proliferation(GO:0070346) negative regulation of ATP biosynthetic process(GO:2001170) |
1.3 | 4.0 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
1.3 | 4.0 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
1.3 | 2.7 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
1.3 | 1.3 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
1.3 | 4.0 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
1.3 | 10.6 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
1.3 | 2.6 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
1.3 | 11.8 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) DNA damage response, signal transduction resulting in transcription(GO:0042772) |
1.3 | 2.6 | GO:0008292 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
1.3 | 13.1 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
1.3 | 3.9 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
1.3 | 5.2 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
1.3 | 10.3 | GO:0030539 | male genitalia development(GO:0030539) |
1.3 | 1.3 | GO:0098815 | modulation of excitatory postsynaptic potential(GO:0098815) |
1.3 | 1.3 | GO:0017085 | response to insecticide(GO:0017085) |
1.3 | 1.3 | GO:0051938 | L-glutamate import(GO:0051938) |
1.3 | 1.3 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
1.3 | 5.1 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
1.3 | 2.5 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
1.3 | 1.3 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
1.3 | 1.3 | GO:0010460 | positive regulation of heart rate(GO:0010460) |
1.3 | 1.3 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
1.3 | 1.3 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
1.3 | 1.3 | GO:0072008 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
1.2 | 1.2 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
1.2 | 22.4 | GO:0015844 | monoamine transport(GO:0015844) |
1.2 | 4.9 | GO:0007258 | JUN phosphorylation(GO:0007258) |
1.2 | 2.5 | GO:2001279 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
1.2 | 12.3 | GO:2001222 | regulation of neuron migration(GO:2001222) |
1.2 | 1.2 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
1.2 | 3.7 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
1.2 | 17.1 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
1.2 | 9.7 | GO:0010863 | activation of phospholipase C activity(GO:0007202) positive regulation of phospholipase C activity(GO:0010863) |
1.2 | 6.0 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
1.2 | 6.0 | GO:0060914 | heart formation(GO:0060914) |
1.2 | 8.3 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
1.2 | 1.2 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
1.2 | 1.2 | GO:0043465 | regulation of fermentation(GO:0043465) regulation of NAD metabolic process(GO:1902688) regulation of glucose catabolic process to lactate via pyruvate(GO:1904023) |
1.2 | 4.7 | GO:0070528 | protein kinase C signaling(GO:0070528) |
1.2 | 4.7 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
1.2 | 1.2 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
1.2 | 3.5 | GO:0050955 | thermoception(GO:0050955) |
1.2 | 1.2 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
1.2 | 3.5 | GO:0006553 | lysine metabolic process(GO:0006553) |
1.2 | 3.5 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
1.2 | 2.3 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
1.2 | 9.2 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
1.2 | 5.8 | GO:0042428 | serotonin metabolic process(GO:0042428) |
1.2 | 6.9 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
1.1 | 5.7 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
1.1 | 3.4 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
1.1 | 10.3 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
1.1 | 6.9 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
1.1 | 2.3 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
1.1 | 2.3 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
1.1 | 17.1 | GO:0007588 | excretion(GO:0007588) |
1.1 | 9.1 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
1.1 | 3.4 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
1.1 | 2.2 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
1.1 | 4.5 | GO:0018158 | protein oxidation(GO:0018158) |
1.1 | 2.2 | GO:0090399 | replicative senescence(GO:0090399) |
1.1 | 13.3 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
1.1 | 2.2 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
1.1 | 2.2 | GO:0048014 | Tie signaling pathway(GO:0048014) |
1.1 | 2.2 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
1.1 | 1.1 | GO:0003348 | cardiac endothelial cell differentiation(GO:0003348) |
1.1 | 1.1 | GO:0031620 | regulation of fever generation(GO:0031620) |
1.1 | 9.7 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
1.1 | 7.6 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
1.1 | 2.2 | GO:0032532 | regulation of microvillus length(GO:0032532) |
1.1 | 4.3 | GO:0006198 | cAMP catabolic process(GO:0006198) |
1.1 | 25.8 | GO:0046847 | filopodium assembly(GO:0046847) |
1.1 | 2.1 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
1.1 | 6.4 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
1.1 | 2.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
1.1 | 2.1 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
1.1 | 9.5 | GO:0030575 | nuclear body organization(GO:0030575) |
1.1 | 1.1 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
1.1 | 5.3 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
1.0 | 4.2 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
1.0 | 1.0 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
1.0 | 11.5 | GO:0070208 | protein heterotrimerization(GO:0070208) |
1.0 | 6.3 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
1.0 | 8.3 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
1.0 | 4.2 | GO:0036315 | cellular response to sterol(GO:0036315) |
1.0 | 2.1 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
1.0 | 4.1 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
1.0 | 3.1 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
1.0 | 4.1 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
1.0 | 2.1 | GO:0046909 | intermembrane transport(GO:0046909) |
1.0 | 3.1 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
1.0 | 4.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
1.0 | 3.1 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
1.0 | 4.1 | GO:0008090 | retrograde axonal transport(GO:0008090) |
1.0 | 4.1 | GO:0043305 | negative regulation of mast cell degranulation(GO:0043305) |
1.0 | 1.0 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
1.0 | 1.0 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
1.0 | 3.0 | GO:0080154 | regulation of fertilization(GO:0080154) |
1.0 | 5.0 | GO:0046836 | glycolipid transport(GO:0046836) |
1.0 | 4.0 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
1.0 | 7.0 | GO:0006012 | galactose metabolic process(GO:0006012) |
1.0 | 6.0 | GO:0070327 | thyroid hormone transport(GO:0070327) |
1.0 | 10.0 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
1.0 | 26.9 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
1.0 | 3.0 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
1.0 | 3.0 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
1.0 | 1.0 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
1.0 | 4.9 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
1.0 | 2.0 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
1.0 | 1.0 | GO:0060439 | trachea morphogenesis(GO:0060439) |
1.0 | 3.9 | GO:0044821 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
1.0 | 20.5 | GO:0009268 | response to pH(GO:0009268) |
1.0 | 1.9 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
1.0 | 5.8 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
1.0 | 1.9 | GO:0060065 | uterus development(GO:0060065) |
1.0 | 2.9 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
1.0 | 2.9 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
1.0 | 1.0 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
1.0 | 2.9 | GO:0034650 | cortisol metabolic process(GO:0034650) |
1.0 | 2.9 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
1.0 | 7.7 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
1.0 | 2.9 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
1.0 | 1.9 | GO:1903232 | melanosome assembly(GO:1903232) |
1.0 | 2.9 | GO:0052428 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
1.0 | 2.9 | GO:0097283 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
1.0 | 1.0 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) |
0.9 | 3.8 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.9 | 2.8 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.9 | 1.9 | GO:0090383 | phagosome acidification(GO:0090383) |
0.9 | 1.9 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.9 | 10.2 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.9 | 1.9 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.9 | 2.8 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.9 | 3.7 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.9 | 9.2 | GO:0008347 | glial cell migration(GO:0008347) |
0.9 | 1.8 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.9 | 6.4 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.9 | 0.9 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.9 | 1.8 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.9 | 2.7 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.9 | 0.9 | GO:0051451 | myoblast migration(GO:0051451) |
0.9 | 1.8 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.9 | 9.9 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.9 | 3.6 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.9 | 9.8 | GO:0033622 | integrin activation(GO:0033622) |
0.9 | 3.6 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.9 | 1.8 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.9 | 2.6 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.9 | 0.9 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.9 | 3.5 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.9 | 1.8 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.9 | 1.7 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.9 | 5.2 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.9 | 49.3 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.9 | 2.6 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.9 | 4.3 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.9 | 6.0 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.9 | 23.2 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
0.9 | 0.9 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.9 | 0.9 | GO:0044533 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) positive regulation of apoptotic process by virus(GO:0060139) |
0.8 | 4.2 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.8 | 1.7 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.8 | 0.8 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
0.8 | 0.8 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.8 | 12.7 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.8 | 2.5 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.8 | 7.6 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.8 | 2.5 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.8 | 2.5 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.8 | 4.2 | GO:0021885 | forebrain cell migration(GO:0021885) |
0.8 | 3.3 | GO:1903044 | protein transport into membrane raft(GO:0032596) protein localization to membrane raft(GO:1903044) |
0.8 | 1.7 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.8 | 3.3 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.8 | 5.0 | GO:0045762 | positive regulation of adenylate cyclase activity(GO:0045762) |
0.8 | 3.3 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.8 | 16.5 | GO:0007340 | acrosome reaction(GO:0007340) |
0.8 | 4.1 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.8 | 0.8 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.8 | 1.6 | GO:2000870 | progesterone secretion(GO:0042701) regulation of progesterone secretion(GO:2000870) |
0.8 | 0.8 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.8 | 5.7 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.8 | 1.6 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.8 | 2.4 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.8 | 4.8 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.8 | 2.4 | GO:0050807 | regulation of synapse organization(GO:0050807) |
0.8 | 2.4 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.8 | 1.6 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.8 | 7.2 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.8 | 1.6 | GO:0014075 | response to amine(GO:0014075) |
0.8 | 4.0 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) |
0.8 | 6.3 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.8 | 44.2 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.8 | 2.4 | GO:0032835 | glomerulus development(GO:0032835) |
0.8 | 4.7 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.8 | 1.6 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.8 | 1.6 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.8 | 3.1 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.8 | 2.3 | GO:0033762 | response to glucagon(GO:0033762) |
0.8 | 10.0 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.8 | 17.6 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.8 | 1.5 | GO:0030432 | peristalsis(GO:0030432) |
0.8 | 8.4 | GO:0036065 | fucosylation(GO:0036065) |
0.8 | 0.8 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.8 | 8.3 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.8 | 0.8 | GO:2001053 | regulation of mesenchymal cell apoptotic process(GO:2001053) |
0.7 | 5.2 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.7 | 2.2 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.7 | 1.5 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.7 | 2.2 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.7 | 6.7 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.7 | 0.7 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.7 | 0.7 | GO:0061525 | hindgut development(GO:0061525) |
0.7 | 1.4 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.7 | 2.1 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.7 | 5.7 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.7 | 3.5 | GO:0048539 | bone marrow development(GO:0048539) |
0.7 | 3.5 | GO:0014002 | astrocyte development(GO:0014002) |
0.7 | 2.1 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.7 | 1.4 | GO:0042637 | catagen(GO:0042637) |
0.7 | 2.8 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.7 | 2.1 | GO:2001212 | regulation of vasculogenesis(GO:2001212) |
0.7 | 1.4 | GO:0033504 | floor plate development(GO:0033504) |
0.7 | 2.1 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.7 | 2.0 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.7 | 2.7 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.7 | 1.3 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.7 | 1.3 | GO:1902475 | L-alpha-amino acid transmembrane transport(GO:1902475) |
0.7 | 0.7 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.7 | 1.3 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.7 | 2.6 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.7 | 2.6 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.7 | 2.0 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.6 | 1.9 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.6 | 0.6 | GO:1900107 | regulation of nodal signaling pathway(GO:1900107) |
0.6 | 14.1 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.6 | 1.3 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.6 | 1.3 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.6 | 0.6 | GO:0060460 | left lung morphogenesis(GO:0060460) |
0.6 | 2.5 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.6 | 8.1 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.6 | 2.5 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.6 | 4.3 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.6 | 2.4 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.6 | 1.2 | GO:0021554 | optic nerve development(GO:0021554) |
0.6 | 3.0 | GO:0001656 | metanephros development(GO:0001656) |
0.6 | 1.8 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.6 | 2.9 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.6 | 0.6 | GO:0060278 | regulation of ovulation(GO:0060278) |
0.6 | 5.2 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.6 | 1.2 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.6 | 4.6 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.6 | 0.6 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.6 | 1.7 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.6 | 1.2 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.6 | 1.2 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
0.6 | 5.2 | GO:0009409 | response to cold(GO:0009409) |
0.6 | 0.6 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.6 | 8.6 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.6 | 0.6 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.6 | 6.9 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.6 | 0.6 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.6 | 13.2 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.6 | 2.3 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.6 | 2.8 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.6 | 2.2 | GO:0032232 | negative regulation of actin filament bundle assembly(GO:0032232) |
0.5 | 0.5 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.5 | 9.1 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.5 | 4.8 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.5 | 9.6 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.5 | 1.0 | GO:0086005 | ventricular cardiac muscle cell action potential(GO:0086005) |
0.5 | 1.0 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.5 | 1.6 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.5 | 0.5 | GO:0032650 | regulation of interleukin-1 alpha production(GO:0032650) |
0.5 | 1.0 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.5 | 19.8 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.5 | 0.5 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.5 | 1.5 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.5 | 2.0 | GO:0001709 | cell fate determination(GO:0001709) |
0.5 | 0.5 | GO:0032831 | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.5 | 4.0 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.5 | 3.0 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.5 | 0.5 | GO:2000391 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.5 | 0.5 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) |
0.5 | 13.6 | GO:0031424 | keratinization(GO:0031424) |
0.5 | 0.5 | GO:0002034 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.5 | 0.5 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.5 | 1.9 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.5 | 6.8 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
0.5 | 8.7 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.5 | 1.4 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.5 | 2.9 | GO:0060736 | prostate gland growth(GO:0060736) |
0.5 | 1.9 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.5 | 1.0 | GO:0009414 | response to water deprivation(GO:0009414) |
0.5 | 0.5 | GO:0018377 | protein myristoylation(GO:0018377) |
0.5 | 1.4 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.5 | 2.8 | GO:0015074 | DNA integration(GO:0015074) |
0.5 | 1.4 | GO:0001502 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.5 | 0.9 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.5 | 3.2 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.5 | 2.3 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.5 | 2.3 | GO:0009624 | response to nematode(GO:0009624) |
0.5 | 0.5 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.5 | 0.5 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.5 | 0.9 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.5 | 1.4 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.5 | 0.5 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.5 | 6.8 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.4 | 0.9 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.4 | 1.8 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.4 | 0.4 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.4 | 0.9 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.4 | 42.6 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
0.4 | 1.3 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.4 | 1.7 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.4 | 1.3 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.4 | 2.5 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.4 | 2.1 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.4 | 3.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.4 | 2.1 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.4 | 1.6 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.4 | 3.3 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.4 | 6.9 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.4 | 4.8 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.4 | 0.8 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.4 | 1.2 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.4 | 0.8 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.4 | 1.6 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.4 | 0.4 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
0.4 | 4.7 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.4 | 1.2 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.4 | 0.8 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.4 | 0.4 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.4 | 0.4 | GO:0048483 | autonomic nervous system development(GO:0048483) |
0.4 | 0.8 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.4 | 0.4 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.4 | 2.6 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.4 | 0.4 | GO:0021756 | striatum development(GO:0021756) |
0.4 | 2.2 | GO:0046471 | phosphatidylglycerol metabolic process(GO:0046471) |
0.4 | 1.1 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.4 | 0.4 | GO:0002339 | B cell selection(GO:0002339) |
0.4 | 5.8 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.4 | 0.4 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.4 | 1.1 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.4 | 1.1 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.4 | 3.6 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.4 | 8.9 | GO:1903845 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.4 | 9.2 | GO:0001764 | neuron migration(GO:0001764) |
0.4 | 0.4 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.4 | 0.4 | GO:0021571 | rhombomere development(GO:0021546) rhombomere 5 development(GO:0021571) |
0.3 | 1.0 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.3 | 1.7 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.3 | 1.7 | GO:0032060 | bleb assembly(GO:0032060) |
0.3 | 0.7 | GO:1902075 | cellular response to salt(GO:1902075) |
0.3 | 0.7 | GO:0070459 | prolactin secretion(GO:0070459) |
0.3 | 8.7 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.3 | 12.7 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.3 | 0.7 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.3 | 1.7 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.3 | 0.3 | GO:0070141 | response to UV-A(GO:0070141) |
0.3 | 0.3 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.3 | 0.6 | GO:0051126 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
0.3 | 0.3 | GO:0060618 | nipple development(GO:0060618) |
0.3 | 0.3 | GO:0050932 | regulation of pigment cell differentiation(GO:0050932) |
0.3 | 0.3 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.3 | 0.6 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.3 | 0.3 | GO:1901201 | regulation of extracellular matrix assembly(GO:1901201) |
0.3 | 0.6 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.3 | 0.3 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.3 | 1.5 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.3 | 0.6 | GO:0071351 | response to interleukin-18(GO:0070673) cellular response to interleukin-18(GO:0071351) |
0.3 | 0.3 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.3 | 0.6 | GO:0019042 | viral latency(GO:0019042) |
0.3 | 0.9 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.3 | 1.4 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.3 | 7.7 | GO:0007566 | embryo implantation(GO:0007566) |
0.3 | 0.6 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.3 | 0.3 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.3 | 0.8 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.3 | 0.3 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.3 | 0.3 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.3 | 1.3 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.3 | 0.8 | GO:0046629 | gamma-delta T cell activation(GO:0046629) |
0.3 | 0.8 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.3 | 0.5 | GO:0060023 | soft palate development(GO:0060023) |
0.3 | 0.3 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.2 | 0.5 | GO:0002676 | regulation of chronic inflammatory response(GO:0002676) |
0.2 | 0.7 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.2 | 1.7 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.2 | 0.5 | GO:0010455 | positive regulation of cell fate commitment(GO:0010455) |
0.2 | 0.2 | GO:0009111 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.2 | 2.8 | GO:0042471 | ear morphogenesis(GO:0042471) |
0.2 | 0.5 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.2 | 0.2 | GO:0060290 | transdifferentiation(GO:0060290) |
0.2 | 2.4 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.2 | 2.4 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.2 | 1.3 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.2 | 0.4 | GO:0007320 | insemination(GO:0007320) |
0.2 | 1.4 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.2 | 1.6 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.2 | 0.8 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) |
0.2 | 0.6 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.2 | 0.2 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0014808) calcium ion transport from endoplasmic reticulum to cytosol(GO:1903514) |
0.2 | 0.4 | GO:0001508 | action potential(GO:0001508) |
0.2 | 0.4 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.2 | 0.4 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.2 | 0.2 | GO:0060022 | hard palate development(GO:0060022) |
0.2 | 0.2 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.2 | 0.5 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.2 | 0.2 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
0.2 | 10.7 | GO:0050890 | cognition(GO:0050890) |
0.2 | 0.5 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 0.5 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.2 | 0.3 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.2 | 6.4 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.2 | 0.6 | GO:0016264 | gap junction assembly(GO:0016264) |
0.2 | 2.9 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.2 | 0.3 | GO:0030878 | thyroid gland development(GO:0030878) |
0.1 | 0.3 | GO:0070587 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.1 | 0.3 | GO:0042640 | anagen(GO:0042640) |
0.1 | 0.4 | GO:0046618 | drug export(GO:0046618) |
0.1 | 0.4 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
0.1 | 0.4 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.1 | 0.1 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.1 | 0.5 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.1 | 0.7 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
0.1 | 0.1 | GO:0007620 | copulation(GO:0007620) |
0.1 | 0.1 | GO:0002775 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
0.1 | 0.4 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.1 | 0.1 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.1 | 2.1 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.1 | 0.8 | GO:0045056 | transcytosis(GO:0045056) |
0.1 | 0.2 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.1 | 0.3 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.1 | 0.1 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.1 | 1.0 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.1 | 0.4 | GO:0042246 | tissue regeneration(GO:0042246) |
0.1 | 1.3 | GO:0006063 | uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) |
0.1 | 0.3 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.1 | 0.4 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.1 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.1 | 0.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.1 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.1 | 0.1 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.1 | 0.2 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.1 | 0.2 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 0.6 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.5 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.1 | 0.1 | GO:1903208 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.1 | 0.1 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.1 | 4.2 | GO:0007601 | visual perception(GO:0007601) |
0.1 | 1.4 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.5 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.1 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.1 | 0.1 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.1 | 0.1 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.1 | 0.2 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.1 | 0.6 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.1 | 0.1 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.1 | 0.1 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
0.1 | 2.4 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.0 | 0.1 | GO:1902572 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.1 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.0 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.0 | 0.2 | GO:0001991 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin(GO:0001991) |
0.0 | 0.1 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.0 | 1.5 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.0 | GO:0070375 | ventricular cardiac myofibril assembly(GO:0055005) ERK5 cascade(GO:0070375) |
0.0 | 0.0 | GO:0098739 | import across plasma membrane(GO:0098739) |
0.0 | 0.1 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.0 | 0.0 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.0 | 3.0 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.2 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.0 | 0.0 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.0 | 0.0 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.0 | GO:2000542 | negative regulation of gastrulation(GO:2000542) |
0.0 | 0.0 | GO:1900274 | regulation of phospholipase C activity(GO:1900274) |
0.0 | 0.0 | GO:0038001 | paracrine signaling(GO:0038001) |
0.0 | 0.1 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.0 | 0.0 | GO:0034505 | tooth mineralization(GO:0034505) |
0.0 | 0.0 | GO:0007632 | visual behavior(GO:0007632) |
0.0 | 0.1 | GO:0015671 | oxygen transport(GO:0015671) |
0.0 | 0.2 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.0 | GO:0014891 | skeletal muscle atrophy(GO:0014732) striated muscle atrophy(GO:0014891) |
0.0 | 0.0 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.0 | 0.0 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.8 | 35.1 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
7.6 | 22.9 | GO:0043259 | laminin-10 complex(GO:0043259) |
7.6 | 45.4 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
7.5 | 30.2 | GO:0044308 | axonal spine(GO:0044308) |
7.0 | 42.2 | GO:0005915 | zonula adherens(GO:0005915) |
6.8 | 47.8 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
6.7 | 20.0 | GO:0072534 | perineuronal net(GO:0072534) |
6.7 | 20.0 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
6.6 | 78.9 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
6.3 | 50.7 | GO:0043083 | synaptic cleft(GO:0043083) |
5.9 | 23.7 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
5.8 | 52.5 | GO:0036128 | CatSper complex(GO:0036128) |
5.8 | 52.3 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
5.5 | 21.9 | GO:0071953 | elastic fiber(GO:0071953) |
5.4 | 5.4 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
5.1 | 60.6 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
5.0 | 55.0 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
4.9 | 44.1 | GO:0043194 | axon initial segment(GO:0043194) |
4.9 | 131.7 | GO:0048786 | presynaptic active zone(GO:0048786) |
4.8 | 87.1 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
4.8 | 33.9 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
4.8 | 14.4 | GO:1990812 | growth cone filopodium(GO:1990812) |
4.7 | 14.1 | GO:0097513 | myosin II filament(GO:0097513) |
4.6 | 13.8 | GO:0097427 | microtubule bundle(GO:0097427) |
4.6 | 64.5 | GO:0030673 | axolemma(GO:0030673) |
4.5 | 13.6 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
4.4 | 35.2 | GO:0030314 | junctional membrane complex(GO:0030314) |
4.4 | 8.7 | GO:1990635 | proximal dendrite(GO:1990635) |
4.4 | 4.4 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
4.3 | 17.3 | GO:0035363 | histone locus body(GO:0035363) |
4.2 | 4.2 | GO:0005606 | laminin-1 complex(GO:0005606) |
4.2 | 71.4 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
4.2 | 16.8 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
4.1 | 24.4 | GO:0031258 | lamellipodium membrane(GO:0031258) |
4.0 | 140.1 | GO:0042734 | presynaptic membrane(GO:0042734) |
3.9 | 11.8 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
3.8 | 19.2 | GO:0045098 | type III intermediate filament(GO:0045098) |
3.7 | 85.8 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
3.6 | 35.6 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
3.5 | 35.3 | GO:0001527 | microfibril(GO:0001527) |
3.5 | 59.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
3.5 | 10.4 | GO:0044393 | microspike(GO:0044393) |
3.3 | 3.3 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
3.3 | 9.9 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
3.3 | 181.2 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
3.2 | 3.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
3.2 | 35.0 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
3.2 | 44.1 | GO:0031045 | dense core granule(GO:0031045) |
3.2 | 25.2 | GO:0030056 | hemidesmosome(GO:0030056) |
3.1 | 9.4 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
3.1 | 24.5 | GO:0042788 | polysomal ribosome(GO:0042788) |
3.0 | 9.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
2.9 | 23.0 | GO:0005861 | troponin complex(GO:0005861) |
2.9 | 17.3 | GO:0016012 | sarcoglycan complex(GO:0016012) |
2.9 | 37.3 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
2.8 | 84.6 | GO:0031941 | filamentous actin(GO:0031941) |
2.8 | 11.2 | GO:0043219 | lateral loop(GO:0043219) |
2.8 | 25.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
2.8 | 5.6 | GO:0043196 | varicosity(GO:0043196) |
2.8 | 41.5 | GO:0005614 | interstitial matrix(GO:0005614) |
2.7 | 8.1 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
2.7 | 24.1 | GO:0000813 | ESCRT I complex(GO:0000813) |
2.7 | 10.7 | GO:1990357 | terminal web(GO:1990357) |
2.7 | 5.3 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
2.7 | 5.3 | GO:0005610 | laminin-5 complex(GO:0005610) |
2.6 | 7.9 | GO:0016342 | catenin complex(GO:0016342) |
2.6 | 10.4 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
2.6 | 7.8 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
2.6 | 10.2 | GO:1990696 | USH2 complex(GO:1990696) |
2.5 | 22.1 | GO:0097542 | ciliary tip(GO:0097542) |
2.4 | 2.4 | GO:0043256 | laminin complex(GO:0043256) |
2.4 | 9.6 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
2.4 | 14.3 | GO:0001652 | granular component(GO:0001652) |
2.3 | 21.1 | GO:0032433 | filopodium tip(GO:0032433) |
2.3 | 9.3 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
2.3 | 2.3 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
2.3 | 20.6 | GO:0032590 | dendrite membrane(GO:0032590) |
2.3 | 9.2 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
2.2 | 11.2 | GO:0070695 | FHF complex(GO:0070695) |
2.2 | 13.2 | GO:0032584 | growth cone membrane(GO:0032584) |
2.2 | 17.4 | GO:0030061 | mitochondrial crista(GO:0030061) |
2.2 | 15.2 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
2.1 | 12.6 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
2.1 | 4.2 | GO:0043511 | inhibin complex(GO:0043511) |
2.1 | 6.3 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
2.1 | 98.6 | GO:0030175 | filopodium(GO:0030175) |
2.1 | 6.2 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
2.0 | 4.1 | GO:0044316 | cone cell pedicle(GO:0044316) |
2.0 | 16.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
2.0 | 264.5 | GO:0045211 | postsynaptic membrane(GO:0045211) |
2.0 | 6.0 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
2.0 | 2.0 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
1.9 | 27.3 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
1.9 | 3.9 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
1.9 | 17.2 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
1.9 | 1.9 | GO:0070820 | tertiary granule(GO:0070820) |
1.9 | 5.7 | GO:0071439 | clathrin complex(GO:0071439) |
1.9 | 7.5 | GO:0045180 | basal cortex(GO:0045180) |
1.8 | 1.8 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
1.8 | 189.8 | GO:0060076 | excitatory synapse(GO:0060076) |
1.8 | 5.5 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
1.8 | 19.9 | GO:0044295 | axonal growth cone(GO:0044295) |
1.8 | 23.5 | GO:0034704 | calcium channel complex(GO:0034704) |
1.8 | 470.1 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
1.8 | 5.3 | GO:0060077 | inhibitory synapse(GO:0060077) |
1.7 | 8.6 | GO:0071547 | piP-body(GO:0071547) |
1.7 | 6.8 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
1.7 | 1.7 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
1.7 | 6.6 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
1.6 | 4.8 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
1.6 | 49.7 | GO:0005581 | collagen trimer(GO:0005581) |
1.6 | 9.5 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.6 | 4.8 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
1.6 | 31.5 | GO:0005922 | connexon complex(GO:0005922) |
1.6 | 7.9 | GO:0031983 | vesicle lumen(GO:0031983) |
1.6 | 4.7 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
1.5 | 6.1 | GO:0043296 | apical junction complex(GO:0043296) |
1.5 | 6.0 | GO:0071203 | WASH complex(GO:0071203) |
1.5 | 8.8 | GO:0005859 | muscle myosin complex(GO:0005859) |
1.5 | 4.4 | GO:0070552 | BRISC complex(GO:0070552) |
1.5 | 5.8 | GO:0030315 | T-tubule(GO:0030315) |
1.4 | 4.3 | GO:0005927 | muscle tendon junction(GO:0005927) |
1.4 | 87.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
1.4 | 1.4 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
1.4 | 4.3 | GO:0005914 | spot adherens junction(GO:0005914) |
1.4 | 4.3 | GO:0044326 | dendritic spine neck(GO:0044326) |
1.4 | 63.2 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
1.4 | 171.1 | GO:0031225 | anchored component of membrane(GO:0031225) |
1.4 | 5.5 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
1.4 | 12.3 | GO:0036156 | inner dynein arm(GO:0036156) |
1.3 | 4.0 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
1.3 | 3.9 | GO:0030478 | actin cap(GO:0030478) |
1.3 | 1.3 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
1.2 | 3.7 | GO:0032585 | multivesicular body membrane(GO:0032585) |
1.2 | 3.7 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
1.2 | 2.4 | GO:0097441 | basilar dendrite(GO:0097441) |
1.2 | 3.6 | GO:0033186 | CAF-1 complex(GO:0033186) |
1.2 | 7.1 | GO:0031143 | pseudopodium(GO:0031143) |
1.2 | 3.6 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
1.2 | 2.3 | GO:0042583 | chromaffin granule(GO:0042583) |
1.2 | 5.8 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
1.1 | 3.4 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
1.1 | 2.3 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
1.1 | 12.4 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
1.1 | 13.3 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
1.1 | 9.6 | GO:0043034 | costamere(GO:0043034) |
1.1 | 11.6 | GO:0005865 | striated muscle thin filament(GO:0005865) |
1.0 | 10.4 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
1.0 | 12.5 | GO:0046930 | pore complex(GO:0046930) |
1.0 | 4.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
1.0 | 3.1 | GO:0032280 | symmetric synapse(GO:0032280) |
1.0 | 32.7 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
1.0 | 4.1 | GO:0000800 | lateral element(GO:0000800) |
1.0 | 19.1 | GO:0030057 | desmosome(GO:0030057) |
1.0 | 3.0 | GO:0034706 | sodium channel complex(GO:0034706) |
1.0 | 49.2 | GO:0031012 | extracellular matrix(GO:0031012) |
1.0 | 25.8 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
1.0 | 1.0 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
1.0 | 2.0 | GO:0097342 | ripoptosome(GO:0097342) |
1.0 | 14.6 | GO:0016328 | lateral plasma membrane(GO:0016328) |
1.0 | 1.9 | GO:0009279 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
1.0 | 4.8 | GO:0071556 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) lumenal side of membrane(GO:0098576) |
1.0 | 13.3 | GO:0043198 | dendritic shaft(GO:0043198) |
0.9 | 2.8 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.9 | 13.2 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.9 | 68.7 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.9 | 27.1 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.9 | 5.4 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.9 | 4.4 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.9 | 4.4 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.8 | 2.5 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.8 | 9.7 | GO:0043657 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.8 | 8.4 | GO:0042555 | MCM complex(GO:0042555) |
0.8 | 2.3 | GO:0097386 | glial cell projection(GO:0097386) |
0.7 | 6.0 | GO:0042383 | sarcolemma(GO:0042383) |
0.7 | 6.0 | GO:0001520 | outer dense fiber(GO:0001520) |
0.7 | 11.9 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.7 | 66.1 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.7 | 32.1 | GO:0030027 | lamellipodium(GO:0030027) |
0.7 | 7.2 | GO:0031932 | TORC2 complex(GO:0031932) |
0.7 | 1.4 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.7 | 5.7 | GO:0036157 | outer dynein arm(GO:0036157) |
0.7 | 2.8 | GO:0070545 | PeBoW complex(GO:0070545) |
0.7 | 6.1 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.7 | 11.5 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.7 | 7.4 | GO:0035102 | PRC1 complex(GO:0035102) |
0.7 | 4.7 | GO:0030904 | retromer complex(GO:0030904) |
0.6 | 0.6 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.6 | 5.8 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.6 | 3.2 | GO:0032426 | stereocilium tip(GO:0032426) |
0.6 | 1.9 | GO:0097422 | tubular endosome(GO:0097422) |
0.6 | 1.3 | GO:0060170 | ciliary membrane(GO:0060170) |
0.6 | 4.9 | GO:0042588 | zymogen granule(GO:0042588) |
0.6 | 8.0 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.6 | 2.4 | GO:0032021 | NELF complex(GO:0032021) |
0.6 | 7.9 | GO:0000145 | exocyst(GO:0000145) |
0.6 | 17.1 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.6 | 3.5 | GO:0031209 | SCAR complex(GO:0031209) |
0.6 | 1.2 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.6 | 1.1 | GO:0005883 | neurofilament(GO:0005883) |
0.6 | 12.7 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.5 | 0.5 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.5 | 0.5 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.5 | 101.0 | GO:0045202 | synapse(GO:0045202) |
0.5 | 0.5 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.5 | 0.5 | GO:1990393 | 3M complex(GO:1990393) |
0.5 | 16.5 | GO:0043204 | perikaryon(GO:0043204) |
0.5 | 1.9 | GO:0042629 | mast cell granule(GO:0042629) |
0.5 | 3.8 | GO:0031901 | early endosome membrane(GO:0031901) |
0.5 | 13.9 | GO:0005884 | actin filament(GO:0005884) |
0.5 | 4.8 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.5 | 5.0 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.5 | 3.6 | GO:0097225 | sperm midpiece(GO:0097225) |
0.5 | 2.3 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.5 | 0.9 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.5 | 0.9 | GO:0097440 | apical dendrite(GO:0097440) |
0.4 | 5.8 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.4 | 6.6 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.4 | 65.4 | GO:0043235 | receptor complex(GO:0043235) |
0.4 | 0.8 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.4 | 0.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.4 | 1.2 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.4 | 1.9 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.4 | 291.8 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.4 | 1.5 | GO:0072687 | meiotic spindle(GO:0072687) |
0.4 | 1.9 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.4 | 7.4 | GO:0016235 | aggresome(GO:0016235) |
0.4 | 8.1 | GO:0031526 | brush border membrane(GO:0031526) |
0.4 | 16.4 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.4 | 0.4 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.3 | 0.7 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.3 | 0.3 | GO:0035838 | growing cell tip(GO:0035838) |
0.3 | 2.3 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.3 | 8.9 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.3 | 1.0 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.3 | 5.4 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.3 | 1.3 | GO:0097546 | ciliary base(GO:0097546) |
0.3 | 3.4 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.3 | 0.3 | GO:0044453 | nuclear membrane part(GO:0044453) |
0.3 | 1.8 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.3 | 0.9 | GO:0042581 | specific granule(GO:0042581) |
0.3 | 14.9 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.3 | 5.6 | GO:0032587 | ruffle membrane(GO:0032587) |
0.3 | 5.5 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.3 | 1.9 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.3 | 0.5 | GO:0000802 | transverse filament(GO:0000802) |
0.3 | 1.5 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.3 | 1.8 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.3 | 8.6 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.3 | 1.0 | GO:0035339 | SPOTS complex(GO:0035339) |
0.2 | 2.0 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.2 | 19.9 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.2 | 1.1 | GO:0005921 | gap junction(GO:0005921) |
0.2 | 0.2 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 6.7 | GO:0045095 | keratin filament(GO:0045095) |
0.2 | 1.0 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.2 | 0.6 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.2 | 0.7 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.2 | 0.5 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.2 | 0.2 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.2 | 0.7 | GO:0097452 | GAIT complex(GO:0097452) |
0.2 | 0.5 | GO:0071817 | MMXD complex(GO:0071817) |
0.2 | 537.6 | GO:0016021 | integral component of membrane(GO:0016021) |
0.2 | 1.2 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 0.9 | GO:0031430 | M band(GO:0031430) |
0.1 | 0.7 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 0.3 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.4 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.1 | 1.6 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 0.4 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 0.4 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 0.1 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 0.4 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 3.4 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 2.6 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 0.1 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.1 | 0.5 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.0 | 0.2 | GO:0042611 | MHC protein complex(GO:0042611) |
0.0 | 0.2 | GO:0097255 | R2TP complex(GO:0097255) |
0.0 | 0.5 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.0 | 0.1 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.0 | 0.2 | GO:0030008 | TRAPP complex(GO:0030008) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
16.0 | 47.9 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
15.4 | 46.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
11.9 | 154.5 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
11.7 | 35.1 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
11.5 | 34.6 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
11.0 | 55.0 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
10.9 | 21.7 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
9.9 | 59.7 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
9.8 | 29.5 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
8.9 | 26.6 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
8.8 | 26.5 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
8.6 | 17.1 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
7.9 | 63.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
7.7 | 23.0 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
7.1 | 35.5 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
7.1 | 85.2 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
7.1 | 21.2 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
7.0 | 49.3 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
6.9 | 20.7 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
6.9 | 20.7 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
6.6 | 26.4 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
6.4 | 25.7 | GO:0038064 | collagen receptor activity(GO:0038064) |
6.4 | 6.4 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
6.1 | 30.5 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
6.1 | 6.1 | GO:0031014 | troponin T binding(GO:0031014) |
5.9 | 17.8 | GO:0035939 | microsatellite binding(GO:0035939) |
5.6 | 28.1 | GO:0048495 | Roundabout binding(GO:0048495) |
5.6 | 27.8 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
5.6 | 38.9 | GO:0003680 | AT DNA binding(GO:0003680) |
5.5 | 38.4 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
5.4 | 27.2 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
5.4 | 49.0 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
5.3 | 68.9 | GO:0031005 | filamin binding(GO:0031005) |
5.2 | 15.7 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
5.2 | 26.0 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
5.2 | 15.6 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
5.1 | 15.4 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
5.1 | 20.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
5.0 | 55.0 | GO:0005522 | profilin binding(GO:0005522) |
4.9 | 88.5 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
4.8 | 14.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
4.7 | 14.2 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
4.7 | 18.9 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
4.7 | 9.4 | GO:0045503 | dynein light chain binding(GO:0045503) |
4.7 | 47.1 | GO:0070411 | I-SMAD binding(GO:0070411) |
4.7 | 14.0 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
4.7 | 28.0 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
4.6 | 13.9 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
4.6 | 22.8 | GO:0070051 | fibrinogen binding(GO:0070051) |
4.5 | 13.6 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
4.5 | 81.6 | GO:0004890 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
4.5 | 31.3 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
4.5 | 13.4 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
4.5 | 17.8 | GO:0032051 | clathrin light chain binding(GO:0032051) |
4.4 | 4.4 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
4.4 | 30.9 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
4.4 | 21.8 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
4.3 | 17.3 | GO:0098821 | BMP receptor activity(GO:0098821) |
4.3 | 29.9 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
4.2 | 12.7 | GO:0070052 | collagen V binding(GO:0070052) |
4.2 | 29.6 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
4.1 | 36.7 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
4.1 | 16.3 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
4.0 | 20.1 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
4.0 | 20.0 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
4.0 | 32.1 | GO:0001972 | retinoic acid binding(GO:0001972) |
4.0 | 119.0 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
3.9 | 35.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
3.9 | 11.7 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
3.9 | 11.6 | GO:0051373 | FATZ binding(GO:0051373) |
3.8 | 19.2 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
3.8 | 19.2 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
3.8 | 11.5 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
3.8 | 15.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
3.7 | 11.2 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
3.7 | 14.9 | GO:0034056 | estrogen response element binding(GO:0034056) |
3.7 | 11.2 | GO:0042731 | PH domain binding(GO:0042731) |
3.7 | 11.0 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
3.7 | 55.1 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
3.7 | 87.8 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
3.7 | 25.6 | GO:1990459 | transferrin receptor binding(GO:1990459) |
3.6 | 3.6 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
3.6 | 18.1 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
3.6 | 14.4 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
3.6 | 14.3 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
3.6 | 3.6 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
3.5 | 113.5 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
3.5 | 10.6 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
3.5 | 34.9 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
3.5 | 10.4 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
3.5 | 13.8 | GO:0004985 | opioid receptor activity(GO:0004985) |
3.4 | 13.7 | GO:0038132 | neuregulin binding(GO:0038132) |
3.3 | 26.5 | GO:0048185 | activin binding(GO:0048185) |
3.3 | 16.6 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
3.3 | 43.1 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
3.3 | 89.0 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
3.3 | 9.8 | GO:0030172 | troponin C binding(GO:0030172) |
3.3 | 6.5 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
3.3 | 6.5 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
3.2 | 31.6 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
3.1 | 28.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
3.1 | 18.6 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
3.1 | 58.1 | GO:0003785 | actin monomer binding(GO:0003785) |
3.0 | 6.1 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
3.0 | 9.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
3.0 | 6.0 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
3.0 | 9.0 | GO:0030284 | estrogen receptor activity(GO:0030284) |
3.0 | 11.9 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
2.9 | 111.7 | GO:0005109 | frizzled binding(GO:0005109) |
2.9 | 35.2 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
2.9 | 11.5 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
2.9 | 23.0 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
2.9 | 8.6 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
2.9 | 14.3 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
2.8 | 5.7 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
2.8 | 36.8 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
2.8 | 11.3 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
2.8 | 28.1 | GO:0050811 | GABA receptor binding(GO:0050811) |
2.8 | 16.9 | GO:0008517 | folic acid transporter activity(GO:0008517) |
2.8 | 14.0 | GO:1990254 | keratin filament binding(GO:1990254) |
2.8 | 36.2 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
2.7 | 32.9 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
2.7 | 10.6 | GO:0034711 | inhibin binding(GO:0034711) |
2.6 | 26.4 | GO:0070700 | BMP receptor binding(GO:0070700) |
2.6 | 7.9 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
2.6 | 207.7 | GO:0019955 | cytokine binding(GO:0019955) |
2.6 | 10.4 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
2.6 | 7.7 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
2.6 | 7.7 | GO:0033142 | progesterone receptor binding(GO:0033142) |
2.6 | 69.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
2.5 | 142.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
2.5 | 2.5 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
2.5 | 5.1 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
2.5 | 5.0 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
2.5 | 7.5 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
2.5 | 12.5 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
2.5 | 5.0 | GO:0044548 | S100 protein binding(GO:0044548) |
2.5 | 44.5 | GO:0005112 | Notch binding(GO:0005112) |
2.5 | 7.4 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
2.5 | 46.7 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
2.4 | 7.3 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
2.4 | 7.2 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
2.4 | 47.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
2.3 | 7.0 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
2.3 | 11.5 | GO:0015189 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
2.3 | 6.9 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
2.3 | 11.5 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
2.3 | 62.0 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
2.3 | 13.7 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
2.3 | 2.3 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
2.3 | 9.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
2.3 | 20.4 | GO:0038191 | neuropilin binding(GO:0038191) |
2.3 | 4.5 | GO:0048763 | ryanodine-sensitive calcium-release channel activity(GO:0005219) calcium-induced calcium release activity(GO:0048763) |
2.3 | 11.3 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
2.3 | 18.1 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
2.2 | 4.4 | GO:0045340 | mercury ion binding(GO:0045340) |
2.2 | 31.1 | GO:0005243 | gap junction channel activity(GO:0005243) |
2.2 | 45.7 | GO:0017147 | Wnt-protein binding(GO:0017147) |
2.1 | 4.3 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
2.1 | 8.3 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
2.1 | 20.8 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
2.1 | 16.4 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
2.0 | 16.4 | GO:0015026 | coreceptor activity(GO:0015026) |
2.0 | 12.3 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
2.0 | 8.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
2.0 | 14.1 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
2.0 | 6.0 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
2.0 | 10.0 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
2.0 | 6.0 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
2.0 | 37.5 | GO:0071837 | HMG box domain binding(GO:0071837) |
1.9 | 5.7 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
1.9 | 17.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
1.9 | 81.8 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
1.9 | 7.6 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
1.9 | 22.5 | GO:0030955 | potassium ion binding(GO:0030955) |
1.9 | 11.2 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
1.8 | 12.9 | GO:0033691 | sialic acid binding(GO:0033691) |
1.8 | 7.3 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
1.8 | 3.7 | GO:0097016 | L27 domain binding(GO:0097016) |
1.8 | 9.0 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
1.8 | 7.2 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
1.8 | 5.3 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
1.8 | 7.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
1.7 | 8.7 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
1.7 | 17.4 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
1.7 | 7.0 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
1.7 | 5.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
1.7 | 39.7 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
1.7 | 6.9 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
1.7 | 8.5 | GO:0004111 | creatine kinase activity(GO:0004111) |
1.7 | 8.4 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
1.7 | 11.7 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
1.7 | 53.2 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
1.7 | 8.3 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
1.6 | 4.9 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
1.6 | 22.8 | GO:0001968 | fibronectin binding(GO:0001968) |
1.6 | 32.3 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
1.6 | 14.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
1.6 | 3.2 | GO:0048019 | receptor antagonist activity(GO:0048019) |
1.6 | 3.2 | GO:0005523 | tropomyosin binding(GO:0005523) |
1.5 | 9.3 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
1.5 | 7.7 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
1.5 | 18.4 | GO:0034185 | apolipoprotein binding(GO:0034185) |
1.5 | 19.9 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
1.5 | 24.4 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
1.5 | 7.6 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
1.5 | 18.2 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
1.5 | 10.6 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
1.5 | 1.5 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
1.5 | 36.4 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
1.5 | 4.4 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
1.4 | 12.9 | GO:0030553 | cGMP binding(GO:0030553) |
1.4 | 53.6 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
1.4 | 2.8 | GO:0070840 | dynein complex binding(GO:0070840) |
1.4 | 19.6 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
1.4 | 5.6 | GO:0030506 | ankyrin binding(GO:0030506) |
1.4 | 5.6 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.4 | 1.4 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
1.4 | 20.6 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
1.4 | 4.1 | GO:0008142 | oxysterol binding(GO:0008142) |
1.4 | 15.1 | GO:0005272 | sodium channel activity(GO:0005272) |
1.4 | 4.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
1.3 | 2.7 | GO:0051380 | norepinephrine binding(GO:0051380) |
1.3 | 5.4 | GO:0017166 | vinculin binding(GO:0017166) |
1.3 | 5.4 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
1.3 | 5.3 | GO:0046923 | ER retention sequence binding(GO:0046923) |
1.3 | 16.0 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
1.3 | 9.3 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
1.3 | 12.0 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
1.3 | 6.6 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
1.3 | 14.5 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
1.3 | 11.8 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
1.3 | 2.6 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
1.3 | 7.8 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
1.3 | 6.4 | GO:0005499 | vitamin D binding(GO:0005499) |
1.3 | 3.8 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
1.3 | 84.0 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
1.3 | 3.8 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
1.3 | 26.4 | GO:0042805 | actinin binding(GO:0042805) |
1.3 | 2.5 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
1.3 | 1.3 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
1.2 | 1.2 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
1.2 | 9.9 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
1.2 | 3.7 | GO:2001069 | glycogen binding(GO:2001069) |
1.2 | 7.3 | GO:0008301 | DNA binding, bending(GO:0008301) |
1.2 | 2.4 | GO:0042289 | MHC class II protein binding(GO:0042289) |
1.2 | 7.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
1.2 | 4.8 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
1.2 | 272.7 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
1.2 | 12.9 | GO:0048038 | quinone binding(GO:0048038) |
1.2 | 7.0 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
1.2 | 7.0 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
1.2 | 8.1 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
1.2 | 11.5 | GO:0043274 | phospholipase binding(GO:0043274) |
1.1 | 4.6 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
1.1 | 12.6 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
1.1 | 2.3 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
1.1 | 8.0 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
1.1 | 93.5 | GO:0008201 | heparin binding(GO:0008201) |
1.1 | 11.4 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
1.1 | 4.5 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
1.1 | 2.3 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
1.1 | 44.9 | GO:0017022 | myosin binding(GO:0017022) |
1.1 | 10.1 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
1.1 | 28.9 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
1.1 | 7.8 | GO:0015172 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
1.1 | 4.4 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
1.1 | 6.6 | GO:0031432 | titin binding(GO:0031432) |
1.1 | 3.3 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
1.1 | 13.1 | GO:0045499 | chemorepellent activity(GO:0045499) |
1.1 | 2.2 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
1.1 | 11.9 | GO:0015643 | toxic substance binding(GO:0015643) |
1.1 | 6.5 | GO:0045295 | gamma-catenin binding(GO:0045295) |
1.1 | 4.3 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
1.1 | 10.7 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
1.1 | 11.7 | GO:0008146 | sulfotransferase activity(GO:0008146) |
1.1 | 14.9 | GO:0016805 | dipeptidase activity(GO:0016805) |
1.1 | 11.6 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
1.1 | 3.2 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
1.0 | 4.2 | GO:0004370 | glycerol kinase activity(GO:0004370) |
1.0 | 1.0 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.0 | 18.8 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
1.0 | 5.2 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
1.0 | 3.1 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
1.0 | 11.5 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
1.0 | 1.0 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
1.0 | 3.1 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
1.0 | 6.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
1.0 | 2.0 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
1.0 | 4.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
1.0 | 25.5 | GO:0005044 | scavenger receptor activity(GO:0005044) |
1.0 | 8.1 | GO:0043422 | protein kinase B binding(GO:0043422) |
1.0 | 2.0 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
1.0 | 3.0 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
1.0 | 1.0 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
1.0 | 10.6 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
1.0 | 4.8 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.9 | 2.8 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.9 | 2.8 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.9 | 0.9 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.9 | 4.6 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.9 | 4.6 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.9 | 82.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.9 | 20.7 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.9 | 2.7 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.9 | 3.5 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.9 | 2.6 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.9 | 2.6 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.9 | 16.7 | GO:0070888 | E-box binding(GO:0070888) |
0.9 | 2.6 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.9 | 10.4 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.9 | 12.1 | GO:0030552 | cAMP binding(GO:0030552) |
0.9 | 2.6 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.8 | 3.4 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.8 | 5.1 | GO:0043495 | protein anchor(GO:0043495) |
0.8 | 9.2 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.8 | 0.8 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.8 | 5.0 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.8 | 0.8 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.8 | 10.8 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.8 | 5.8 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.8 | 4.9 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.8 | 0.8 | GO:0031402 | sodium ion binding(GO:0031402) |
0.8 | 1.6 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.8 | 29.0 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.8 | 23.3 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.8 | 48.9 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.8 | 3.2 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.8 | 3.2 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.8 | 86.3 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.8 | 196.9 | GO:0003779 | actin binding(GO:0003779) |
0.8 | 24.1 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.8 | 5.3 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.7 | 5.2 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.7 | 252.8 | GO:0005509 | calcium ion binding(GO:0005509) |
0.7 | 11.5 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.7 | 5.7 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.7 | 1.4 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
0.7 | 2.1 | GO:0048030 | disaccharide binding(GO:0048030) |
0.7 | 2.7 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.7 | 10.1 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.7 | 1.3 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.7 | 7.3 | GO:0051400 | BH domain binding(GO:0051400) |
0.7 | 10.6 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.7 | 2.0 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.7 | 2.0 | GO:0002046 | opsin binding(GO:0002046) |
0.7 | 4.6 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.6 | 5.2 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.6 | 0.6 | GO:0038100 | nodal binding(GO:0038100) |
0.6 | 1.9 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.6 | 1.2 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.6 | 3.6 | GO:0043236 | laminin binding(GO:0043236) |
0.6 | 1.8 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.6 | 1.8 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.6 | 1.8 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.6 | 5.3 | GO:0015298 | solute:cation antiporter activity(GO:0015298) |
0.6 | 1.2 | GO:0032190 | acrosin binding(GO:0032190) |
0.6 | 10.5 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.6 | 1.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.6 | 10.9 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.6 | 2.3 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.6 | 2.3 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.6 | 1.7 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.5 | 0.5 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.5 | 15.7 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.5 | 0.5 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.5 | 1.6 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.5 | 2.6 | GO:0033265 | choline binding(GO:0033265) |
0.5 | 1.0 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.5 | 23.9 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.5 | 1.0 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.5 | 14.8 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.5 | 0.5 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
0.5 | 1.5 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.5 | 9.5 | GO:0050699 | WW domain binding(GO:0050699) |
0.5 | 87.1 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.5 | 9.8 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.5 | 2.0 | GO:0034584 | piRNA binding(GO:0034584) |
0.5 | 1.9 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.5 | 1.4 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.5 | 9.3 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.5 | 2.7 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.5 | 3.6 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.4 | 1.3 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.4 | 0.8 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.4 | 1.2 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.4 | 23.3 | GO:0008083 | growth factor activity(GO:0008083) |
0.4 | 0.4 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.4 | 4.0 | GO:0003905 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.4 | 1.6 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.4 | 2.0 | GO:0004854 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.4 | 2.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.4 | 1.6 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.4 | 3.1 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.4 | 1.1 | GO:0004096 | catalase activity(GO:0004096) |
0.4 | 29.9 | GO:0005179 | hormone activity(GO:0005179) |
0.4 | 1.5 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.4 | 4.1 | GO:0070402 | NADPH binding(GO:0070402) |
0.4 | 0.4 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.4 | 1.1 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.4 | 0.4 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.4 | 1.5 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.4 | 1.8 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.4 | 1.1 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.4 | 1.8 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.3 | 1.0 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.3 | 1.0 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.3 | 0.7 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.3 | 2.0 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.3 | 1.0 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.3 | 0.9 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.3 | 0.9 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.3 | 0.6 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.3 | 9.1 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.3 | 1.2 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.3 | 0.3 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.3 | 0.3 | GO:0043199 | sulfate binding(GO:0043199) |
0.3 | 131.1 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.3 | 7.6 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.3 | 0.3 | GO:0031013 | troponin I binding(GO:0031013) |
0.3 | 0.3 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.3 | 0.8 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.3 | 0.8 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.3 | 0.8 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.3 | 3.4 | GO:0003774 | motor activity(GO:0003774) |
0.3 | 0.5 | GO:0030519 | snoRNP binding(GO:0030519) |
0.3 | 3.8 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.2 | 1.7 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.2 | 0.2 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 0.2 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.2 | 4.9 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 0.6 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.2 | 4.4 | GO:0005518 | collagen binding(GO:0005518) |
0.2 | 2.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.2 | 0.4 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.2 | 0.4 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.2 | 4.0 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 0.5 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.2 | 0.9 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.2 | 0.9 | GO:0018856 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.2 | 0.5 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.2 | 1.5 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.2 | 0.8 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.2 | 12.2 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.2 | 0.8 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 2.3 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.4 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 0.4 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 0.6 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 1.4 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.1 | 0.8 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 3.5 | GO:0043826 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
0.1 | 0.1 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.1 | 0.1 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.1 | 0.4 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 1.4 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.3 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.1 | 1.0 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 13.1 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 0.9 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 0.2 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.1 | 0.5 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
0.1 | 0.2 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.1 | 0.2 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
0.1 | 0.4 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.6 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 0.3 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.1 | 1.4 | GO:0005267 | potassium channel activity(GO:0005267) |
0.1 | 0.7 | GO:0052769 | dextrin alpha-glucosidase activity(GO:0044653) starch alpha-glucosidase activity(GO:0044654) beta-glucanase activity(GO:0052736) beta-6-sulfate-N-acetylglucosaminidase activity(GO:0052769) glucan endo-1,4-beta-glucosidase activity(GO:0052859) |
0.1 | 0.7 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.6 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 1.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.1 | GO:0015927 | trehalase activity(GO:0015927) |
0.1 | 0.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 0.1 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 0.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 5.0 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
0.1 | 0.2 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.0 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.0 | 1.2 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.0 | 0.0 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.0 | 0.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.0 | 0.0 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.0 | 0.2 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 1.7 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.2 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 6.0 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.1 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.3 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 0.1 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
14.6 | 14.6 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
4.6 | 111.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
4.6 | 50.8 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
4.1 | 174.6 | NABA COLLAGENS | Genes encoding collagen proteins |
3.5 | 7.0 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
3.4 | 98.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
3.3 | 6.6 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
3.2 | 9.6 | PID S1P S1P3 PATHWAY | S1P3 pathway |
3.1 | 46.8 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
3.1 | 55.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
2.9 | 82.2 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
2.9 | 71.9 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
2.8 | 8.5 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
2.8 | 8.3 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
2.7 | 114.6 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
2.7 | 10.6 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
2.6 | 39.7 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
2.6 | 77.6 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
2.6 | 2.6 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
2.6 | 5.2 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
2.4 | 59.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
2.4 | 16.6 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
2.3 | 25.6 | PID ALK2 PATHWAY | ALK2 signaling events |
2.3 | 27.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
2.2 | 53.7 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
2.1 | 25.0 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
2.1 | 14.5 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
2.1 | 4.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
2.0 | 16.1 | PID ALK1 PATHWAY | ALK1 signaling events |
2.0 | 316.2 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
1.9 | 26.7 | PID REELIN PATHWAY | Reelin signaling pathway |
1.9 | 1.9 | PID S1P S1P1 PATHWAY | S1P1 pathway |
1.8 | 30.8 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
1.7 | 13.7 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
1.7 | 51.8 | PID BMP PATHWAY | BMP receptor signaling |
1.6 | 26.7 | PID FGF PATHWAY | FGF signaling pathway |
1.6 | 404.0 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
1.5 | 1.5 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
1.5 | 26.5 | PID RAS PATHWAY | Regulation of Ras family activation |
1.4 | 188.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
1.3 | 16.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
1.3 | 9.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
1.3 | 43.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
1.3 | 19.6 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
1.3 | 13.0 | ST G ALPHA S PATHWAY | G alpha s Pathway |
1.3 | 25.9 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
1.3 | 17.9 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
1.2 | 33.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
1.2 | 9.3 | PID S1P S1P4 PATHWAY | S1P4 pathway |
1.1 | 21.7 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
1.1 | 11.9 | PID EPHB FWD PATHWAY | EPHB forward signaling |
1.0 | 27.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
1.0 | 7.8 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.9 | 7.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.9 | 18.7 | PID AURORA A PATHWAY | Aurora A signaling |
0.9 | 4.4 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.8 | 12.6 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.8 | 24.9 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.8 | 16.5 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.8 | 1.5 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.7 | 2.8 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.7 | 8.5 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.7 | 9.6 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.7 | 133.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.6 | 4.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.6 | 1.8 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.6 | 0.6 | PID SHP2 PATHWAY | SHP2 signaling |
0.6 | 1.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.5 | 27.4 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.5 | 1.5 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.5 | 9.3 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.4 | 9.2 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.4 | 1.7 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.4 | 1.5 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.4 | 9.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.3 | 4.7 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.3 | 0.8 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.3 | 7.1 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.2 | 3.6 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.2 | 1.9 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.2 | 0.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 0.6 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.2 | 2.6 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 1.2 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.2 | 1.0 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.2 | 1.7 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 5.5 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 0.3 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 0.6 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 2.2 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 1.6 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 0.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.1 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 0.0 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 0.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.8 | 8.8 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
7.6 | 7.6 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
6.7 | 6.7 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
6.5 | 176.6 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
6.1 | 72.9 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
6.1 | 85.0 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
5.2 | 78.7 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
5.1 | 178.8 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
4.9 | 43.7 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
4.6 | 179.4 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
4.5 | 40.5 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
4.2 | 59.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
4.2 | 95.7 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
4.1 | 176.3 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
3.8 | 3.8 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
3.8 | 87.2 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
3.7 | 44.2 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
3.7 | 14.6 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
3.7 | 40.2 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
3.6 | 50.9 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
3.6 | 10.8 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
3.6 | 3.6 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
3.6 | 3.6 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
3.5 | 46.1 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
3.5 | 45.6 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
3.5 | 38.1 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
3.4 | 123.8 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
3.4 | 37.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
3.3 | 32.6 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
3.2 | 32.0 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
3.2 | 3.2 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
3.2 | 69.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
3.1 | 71.9 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
2.8 | 16.9 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
2.7 | 8.2 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
2.7 | 24.5 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
2.7 | 27.2 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
2.7 | 21.4 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
2.3 | 9.2 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
2.3 | 6.8 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
2.2 | 24.6 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
2.2 | 6.6 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
2.2 | 28.1 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
2.1 | 82.6 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
2.0 | 40.3 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
2.0 | 36.2 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
2.0 | 2.0 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
2.0 | 33.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
1.9 | 1.9 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
1.9 | 11.6 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
1.9 | 153.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
1.8 | 27.6 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
1.7 | 45.0 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
1.6 | 17.6 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
1.6 | 25.4 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
1.5 | 12.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
1.4 | 1.4 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
1.4 | 22.3 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
1.4 | 38.5 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
1.3 | 21.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
1.3 | 4.0 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
1.3 | 10.6 | REACTOME OPSINS | Genes involved in Opsins |
1.3 | 7.9 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
1.3 | 6.3 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
1.2 | 9.8 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
1.2 | 13.2 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
1.2 | 9.5 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
1.2 | 83.8 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
1.1 | 45.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
1.1 | 23.8 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
1.1 | 16.2 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
1.1 | 20.5 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
1.1 | 7.4 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
1.1 | 1.1 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
1.0 | 7.0 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
1.0 | 20.1 | REACTOME KINESINS | Genes involved in Kinesins |
0.9 | 12.8 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.9 | 10.9 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.9 | 8.0 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.9 | 0.9 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.9 | 9.5 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.9 | 13.0 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.9 | 6.8 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.9 | 2.6 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.8 | 10.0 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.8 | 4.9 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.8 | 1.6 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.8 | 14.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.8 | 18.5 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.8 | 5.3 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.8 | 9.8 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.7 | 3.6 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.7 | 31.8 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.7 | 10.5 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.6 | 2.6 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.6 | 3.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.6 | 0.6 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.6 | 13.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.6 | 6.9 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.6 | 4.0 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.6 | 1.7 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.5 | 4.9 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.5 | 56.5 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.5 | 0.5 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.5 | 12.1 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.5 | 4.5 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.5 | 9.8 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.4 | 1.8 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.4 | 40.8 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.4 | 1.8 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.4 | 1.5 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.4 | 4.6 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.4 | 4.5 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.3 | 0.3 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.3 | 2.6 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.3 | 4.7 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.3 | 15.0 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.2 | 0.7 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.2 | 5.5 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.2 | 0.5 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.2 | 1.5 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.2 | 4.4 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.2 | 0.7 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.2 | 15.7 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.2 | 1.8 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.2 | 0.7 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 0.1 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.1 | 2.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 0.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.4 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.0 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.0 | 0.1 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.1 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.0 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 0.1 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |